Maximilian Diehn, MD, PhD

5.0/5

10 Patient Ratings

46 Patient Reviews

Maximilian Diehn, MD, PhD

Radiation oncologist

Jack, Lulu, and Sam Willson Professor and Professor of Radiation Oncology (Radiation Therapy)

View Professional Summary

Additional Languages Spoken:

German

Insurance Coverage

Online Second Opinion Program

Resources for Referring Physicians

Professional Summary

Education & Certifications

Residency: Stanford University Dept of Radiation Oncology (2009) CA
Medical Education: Stanford University School of Medicine (2004) CA
Internship: Stanford University Internal Medicine Residency (2005) CA
- Board Certification: American Board of Radiology, Radiation Oncology (2010)
- MD, Stanford University (2004)
- PhD, Stanford University, Biophysics (2004)
- AB, Harvard College, Biochemical Sciences (1997)

View More Education & Certifications

Honors & Awards

American Red Cross Blood Services Hero Award, American Red Cross (2016)
Annual Meeting Basic Science Travel Grant Award, American Society for Therapeutic Radiology and Oncology (ASTRO) (2006)
ASCO Leadership Development Program, American Society of Clinical Oncology (ASCO) (2017-2018)
- ASTRO Residents in Radiation Oncology Research Seed Grant, American Society for Therapeutic Radiology and Oncology (ASTRO) (2006-2008)
- CRK Faculty Scholar, CRK (2012-present)
- Donald E. and Delia B. Baxter Foundation Faculty Scholar Award, Donald E. and Delia B. Baxter Foundation (2011-2012)
- Doris Duke Clinical Scientist Development Award, Doris Duke Charitable Foundation (2010-2014)
- Edward Mallinckrodt, Jr. Foundation Grant, Edward Mallinckrodt, Jr. Foundation (2010-2014)
- Elected to the National Academy of Medicine, National Academy of Medicine (NAM) (2021)
- Election to American Society for Clinical Investigation, American Society for Clinical Investigation (ASCI) (2017)
- Franklin G. Ebaugh, Jr. Award for Research, Department of Medicine, Stanford University (2005)
- Henry S. Kaplan Memorial Prize for Teaching, Stanford University (2012)
- Holman Research Pathway, American Board of Radiology (ABR) (2006-2009)
- Lung Cancer Research Program Promising Clinician Research Award, Department of Defense (2012-2014)
- Malcolm A. Bagshaw Award, Stanford University (2009)
- Medical Scientist Training Program, Stanford University (1997-2004)
- NIH Director's New Innovator Award, National Institute of Health (NIH) (2013-2018)
- Roentgen Resident/Fellow Research Award, Radiological Society of North America (RSNA) (2008)
- RSNA Research Resident/Fellow Grant, Radiological Society of North America (RSNA) (2007-2009)
- Sidney Kimmel Scholar Award, Sidney Kimmel Foundation (2010-2013)
- Thomas Temple Hoopes Prize for outstanding senior thesis, Harvard University (1997)
- V Foundation Scholar Grant, V Foundation (2013-2015)
- Walter H. Coulter Translational Research Grant, Walter H. Coulter Foundation (2013-2014)

View More Honors & Awards

Memberships

Member, American Society for Therapeutic Radiology and Oncology (ASTRO) (2004 - Present)
Member, Radiological Society of North America (RSNA) (2004 - Present)
Member, International Society for Stem Cell Research (ISSCR) (2010 - Present)
- Member, International Association for the Study of Lung Cancer (IASLC) (2011 - Present)

View More Memberships

Administrative Appointments

Cancer Biology Graduate Program Admissions Committee, Stanford University (2012 - Present)
Medical Scientist Training Program (MSTP) Admissions Committee, Stanford University (2011 - Present)
Stem Cell Biology & Regenerative Medicine Graduate Program Admissions Committee, Stanford University (2013 - Present)

Publications

Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade
Bunnell, S. C., Diehn, M., Yaffe, M. B., Findell, P. R., Cantley, L. C., & Berg, L. J. (2000). Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(3), 2219–2230.
Large-scale identification of secreted and membrane-associated gene products using DNA microarrays
Diehn, M., Eisen, M. B., Botstein, D., & Brown, P. O. (2000). Large-scale identification of secreted and membrane-associated gene products using DNA microarrays. NATURE GENETICS, 25(1), 58–62.
Examining the living genome in health and disease with DNA microarrays
Diehn, M., Alizadeh, A. A., & Brown, P. O. (2000). Examining the living genome in health and disease with DNA microarrays. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 283(17), 2298–99.
- Degradation of proteins from the ER of S-cerevisiae requires an intact unfolded protein response pathway
  Casagrande, R., Stern, P., Diehn, M., Shamu, C., Osario, M., Zuniga, M., … Ploegh, H. (2000). Degradation of proteins from the ER of S-cerevisiae requires an intact unfolded protein response pathway. MOLECULAR CELL, 5(4), 729–735.
- Comparing functional genomic datasets: lessons from DNA. microarray analyses of host-pathogen interactions
  Diehn, M., & Relman, D. A. (2001). Comparing functional genomic datasets: lessons from DNA. microarray analyses of host-pathogen interactions. CURRENT OPINION IN MICROBIOLOGY, 4(1), 95–101.
- Stereotyped and specific gene expression programs in human innate immune responses to bacteria
  Boldrick, J. C., Alizadeh, A. A., Diehn, M., Dudoit, S., Liu, C. L., Belcher, C. E., … Relman, D. A. (2002). Stereotyped and specific gene expression programs in human innate immune responses to bacteria. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99(2), 972–77.
- In vivo regulation of human skeletal muscle gene expression by thyroid hormone
  Clement, K., Viguerie, N., Diehn, M., Alizadeh, A., Barbe, P., Thalamas, C., … Langin, D. (2002). In vivo regulation of human skeletal muscle gene expression by thyroid hormone. GENOME RESEARCH, 12(2), 281–91.
- Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes
  Lossos, I. S., Alizadeh, A. A., Diehn, M., Warnke, R., Thorstenson, Y., Oefner, P. J., … Levy, R. (2002). Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99(13), 8886–91.
- Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11.
  Sayama, K., Diehn, M., Matsuda, K., Lunderius, C., Tsai, M., Tam, S.-Y., … Galli, S. J. (2002). Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11. BMC Immunology, 3, 5-?
- Transcriptional programs activated by exposure of human prostate cancer cells to androgen
  DePrimo, S. E., Diehn, M., Nelson, J. B., Reiter, R. E., Matese, J., Fero, M., … Brooks, J. D. (2002). Transcriptional programs activated by exposure of human prostate cancer cells to androgen. GENOME BIOLOGY, 3(7).
- Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation
  Diehn, M., Alizadeh, A. A., Rando, O. J., Liu, C. L., Stankunas, K., Botstein, D., … Brown, P. O. (2002). Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99(18), 11796–801.
- SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data
  Diehn, M., Sherlock, G., Binkley, G., Jin, H., Matese, J. C., Hernandez-Boussard, T., … Alizadeh, A. A. (2003). SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. NUCLEIC ACIDS RESEARCH, 31(1), 219–23.
- Individuality and variation in gene expression patterns in human blood
  Whitney, A. R., Diehn, M., Popper, S. J., Alizadeh, A. A., Boldrick, J. C., Relman, D. A., & Brown, P. O. (2003). Individuality and variation in gene expression patterns in human blood. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 100(4), 1896–1901.
- Gene expression patterns in ovarian carcinomas
  Schaner, M. E., Ross, D. T., Ciaravino, G., Sorlie, T., Troyanskaya, O., Diehn, M., … Sikic, B. I. (2003). Gene expression patterns in ovarian carcinomas. MOLECULAR BIOLOGY OF THE CELL, 14(11), 4376–86.
- T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression.
  Roose, J. P., Diehn, M., Tomlinson, M. G., Lin, J., Alizadeh, A. A., Botstein, D., … Weiss, A. (2003). T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. PLoS Biology, 1(2), E53-?
- Presynaptic homeostasis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway
  Piedras-Renteria, E. S., Pyle, J. L., Diehn, M., Glickfeld, L. L., Harata, N. C., Cao, Y. Q., … Tsien, R. W. (2004). Presynaptic homeostasis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 101(10), 3609–14.
- A method for detecting and correcting feature misidentification on expression microarrays
  Tu, I. P., Schaner, M., Diehn, M., Sikic, B. I., Brown, P. O., Botstein, D., & Fero, M. J. (2004). A method for detecting and correcting feature misidentification on expression microarrays. BMC GENOMICS, 5.
- Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme
  Liang, Y., Diehn, M., Watson, N., Bollen, A. W., Aldape, K. D., Nicholas, M. K., … Israel, M. A. (2005). Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 102(16), 5814–5819.
- Differential gene expression in anatomical compartments of the human eye
  Diehn, J. J., Diehn, M., Marmor, M. F., & Brown, P. O. (2005). Differential gene expression in anatomical compartments of the human eye. GENOME BIOLOGY, 6(9).
- Genome-scale identification of membrane-associated human mRNAs
  Diehn, M., Bhattacharya, R., Botstein, D., & Brown, P. O. (2006). Genome-scale identification of membrane-associated human mRNAs. PLOS GENETICS, 2(1), 39–50.
- Cell-type specific gene expression profiles of leukocytes in human peripheral blood
  Palmer, C., Diehn, M., Alizadeh, A. A., & Brown, P. O. (2006). Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC GENOMICS, 7.
- Cancer stem cells and radiotherapy: New insights into tumor radioresistance
  Diehn, M., & Clarke, M. F. (2006). Cancer stem cells and radiotherapy: New insights into tumor radioresistance. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 98(24), 1755–1757.
- Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment
  Liang, Y., Diehn, M., Bollen, A. W., Israel, M. A., & Gupta, N. (2008). Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment. JOURNAL OF NEURO-ONCOLOGY, 86(2), 133–141.
- Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors
  Cho, R. W., Wang, X., Diehn, M., Shedden, K., Chen, G. Y., Sherlock, G., … Clarke, M. F. (2008). Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. STEM CELLS, 26(2), 364–71.
- Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
  Diehn, M., Nardini, C., Wang, D. S., McGovern, S., Jayaraman, M., Liang, Y., … Kuo, M. D. (2008). Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 105(13), 5213–18.
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
  Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., … Clarke, M. F. (2009). Association of reactive oxygen species levels and radioresistance in cancer stem cells. NATURE, 458(7239), 780–U123.
- Therapeutic Implications of the Cancer Stem Cell Hypothesis
  Diehn, M., Cho, R. W., & Clarke, M. F. (2009). Therapeutic Implications of the Cancer Stem Cell Hypothesis. SEMINARS IN RADIATION ONCOLOGY, 19(2), 78–86.
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
  Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., Qian, D., … Clarke, M. F. (2009). Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells. CELL, 138(3), 592–603.
- Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
  Chan, K. S., Espinosa, I., Chao, M., Wong, D., Ailles, L., Diehn, M., … Weissman, I. L. (2009). Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 106(33), 14016–21.
- Metastatic Cancer Stem Cells: An Opportunity for Improving Cancer Treatment?
  Diehn, M., & Majeti, R. (2010). Metastatic Cancer Stem Cells: An Opportunity for Improving Cancer Treatment? CELL STEM CELL, 6(6), 502–3.
- HIGH RETENTION AND SAFETY OF PERCUTANEOUSLY IMPLANTED ENDOVASCULAR EMBOLIZATION COILS AS FIDUCIAL MARKERS FOR IMAGE-GUIDED STEREOTACTIC ABLATIVE RADIOTHERAPY OF PULMONARY TUMORS
  Hong, J. C., Yu, Y., Rao, A. K., Ditererich, S., Maxim, P. G., Le, Q.-T., … Loo, B. W. (2011). HIGH RETENTION AND SAFETY OF PERCUTANEOUSLY IMPLANTED ENDOVASCULAR EMBOLIZATION COILS AS FIDUCIAL MARKERS FOR IMAGE-GUIDED STEREOTACTIC ABLATIVE RADIOTHERAPY OF PULMONARY TUMORS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(1), 85–90.
- STEREOTACTIC ABLATIVE RADIOTHERAPY SHOULD BE COMBINED WITH A HYPOXIC CELL RADIOSENSITIZER
  Brown, J. M., Diehn, M., & Loo, B. W. (2010). STEREOTACTIC ABLATIVE RADIOTHERAPY SHOULD BE COMBINED WITH A HYPOXIC CELL RADIOSENSITIZER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(2), 323–27.
- The Myc Connection: ES Cells and Cancer
  Rothenberg, M. E., Clarke, M. F., & Diehn, M. (2010). The Myc Connection: ES Cells and Cancer. CELL, 143(2), 184–86.
- Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer
  Kozak, M. M., Murphy, J. D., Schipper, M. L., Donington, J. S., Zhou, L., Whyte, R. I., … Loo, B. W. (2011). Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 6(5), 920–26.
- Reducing 4D CT artifacts using optimized sorting based on anatomic similarity
  Johnston, E., Diehn, M., Murphy, J. D., Loo, B. W., & Maxim, P. G. (2011). Reducing 4D CT artifacts using optimized sorting based on anatomic similarity. MEDICAL PHYSICS, 38(5), 2424–29.
- What the Diagnostic Radiologist Needs to Know about Radiation Oncology
  Terezakis, S. A., Heron, D. E., Lavigne, R. F., Diehn, M., & Loo, B. W. (2011). What the Diagnostic Radiologist Needs to Know about Radiation Oncology. RADIOLOGY, 261(1), 30–44.
- Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors
  Trakul, N., Chang, C. N., Harris, J., Chapman, C., Rao, A., Shen, J., … Diehn, M. (2012). Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(1), 231–37.
- Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images
  Li, R., Mok, E., Chang, D. T., Daly, M., Loo, B. W., Diehn, M., … Xing, L. (2012). Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(5), E709–E715.
- Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors
  Trakul, N., Harris, J. P., Le, Q.-T., Hara, W. Y., Maxim, P. G., Loo, B. W., & Diehn, M. (2012). Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors. JOURNAL OF THORACIC ONCOLOGY, 7(9), 1462–65.
- Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy.
  Abelson, J. A., Murphy, J. D., Trakul, N., Bazan, J. G., Maxim, P. G., Graves, E. E., … Loo, B. W. (2012). Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. Lung Cancer , 78(3), 219–24.
- Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy.
  Hong, J. C., Eclov, N. C. W., Yu, Y., Rao, A. K., Dieterich, S., Le, Q.-T., … Maxim, P. G. (2013). Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy. Journal of Applied Clinical Medical Physics , 14(2), 4046-?
- T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression
  Roose, J. P., Diehn, M., Tomlinson, M. G., Lin, J., Alizadeh, A. A., Botstein, D., … Weiss, A. (2003). T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. PLOS BIOLOGY, 1(2), 271–87.
- Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy
  Hong, J. C., Eclov, N. C. W., Yu, Y., Rao, A. K., Dieterich, S., Quynh-Thu Le, Q. T., … Maxim, P. G. (2013). Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 14(2), 77–89.
- The Optimal Use of Radiotherapy in Small Cell Lung Cancer
  Shultz, D. B., Grecula, J. C., Hayman, J., Diehn, M., & Loo, B. W. (2013). The Optimal Use of Radiotherapy in Small Cell Lung Cancer. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 11(1), 107–114.
- 4D CT lung ventilation images are affected by the 4D CT sorting method.
  Yamamoto, T., Kabus, S., Lorenz, C., Johnston, E., Maxim, P. G., Diehn, M., … Keall, P. J. (2013). 4D CT lung ventilation images are affected by the 4D CT sorting method. Medical Physics, 40(10), 101907-?
- Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy.
  Li, R., Han, B., Meng, B., Maxim, P. G., Xing, L., Koong, A. C., … Loo, B. W. (2013). Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 87(5), 917–23.
- Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal
  Zhou, B., Damrauer, J. S., Bailey, S. T., Hadzic, T., Jeong, Y., Clark, K., … Kim, W. Y. (2014). Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal. JOURNAL OF CLINICAL INVESTIGATION, 124(2), 553–63.
- Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.
  Jamshidi, N., Diehn, M., Bredel, M., & Kuo, M. D. (2014). Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. Radiology, 270(1), 1–2.
- Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor-Initiating Cells by Triggering HER2/HER3 Activation
  Lee, C. Y.-F., Lin, Y., Bratman, S. V., Feng, W., Kuo, A. H., Scheeren, F. A., … Diehn, M. (2014). Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor-Initiating Cells by Triggering HER2/HER3 Activation. CANCER RESEARCH, 74(1), 341–52.
- A Population-Based Comparative Effectiveness Study of Radiation Therapy Techniques in Stage III Non-Small Cell Lung Cancer.
  Harris, J. P., Murphy, J. D., Hanlon, A. L., Le, Q.-T., Loo, B. W., & Diehn, M. (2014). A Population-Based Comparative Effectiveness Study of Radiation Therapy Techniques in Stage III Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics, 88(4), 872–84.
- Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors.
  Liu, M. B., Eclov, N. C. W., Trakul, N., Murphy, J., Diehn, M., Le, Q.-T., … Loo, B. W. (2013). Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors. Practical Radiation Oncology, 3(4), 294–300.
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
  Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., … Diehn, M. (2014). An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. NATURE MEDICINE, 20(5), 552–58.
- The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy.
  Shultz, D. B., Jang, S. S., Hanlon, A. L., Diehn, M., Loo, B. W., & Maxim, P. G. (2014). The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy. Practical Radiation Oncology, 4(3), 192–97.
- Feasibility and Potential Utility of Multicomponent Exhaled Breath Analysis for Predicting Development of Radiation Pneumonitis After Stereotactic Ablative Radiotherapy
  More, J. M., Eclov, N. C. W., Chung, M. P., Wynne, J. F., Shorter, J. H., Nelson, D. D., … Diehn, M. (2014). Feasibility and Potential Utility of Multicomponent Exhaled Breath Analysis for Predicting Development of Radiation Pneumonitis After Stereotactic Ablative Radiotherapy. JOURNAL OF THORACIC ONCOLOGY, 9(7), 957–64.
- Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer.
  Shultz, D. B., Trakul, N., Abelson, J. A., Murphy, J. D., Maxim, P. G., Le, Q.-T., … Diehn, M. (2014). Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer. Clinical Lung Cancer, 15(4), 294–301 e3.
- Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest.
  Shultz, D. B., Trakul, N., Maxim, P. G., Diehn, M., & Loo, B. W. (2014). Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest. Practical Radiation Oncology, 4(4), 272–78.
- Targeting Unique Metabolic Properties of Breast Tumor Initiating Cells
  Feng, W., Gentles, A., Nair, R. V., Huang, M., Lin, Y., Lee, C. Y., … Diehn, M. (2014). Targeting Unique Metabolic Properties of Breast Tumor Initiating Cells. STEM CELLS, 32(7), 1734–45.
- Neurotrophic factor GDNF promotes survival of salivary stem cells.
  Xiao, N., Lin, Y., Cao, H., Sirjani, D., Giaccia, A. J., Koong, A. C., … Le, Q.-T. (2014). Neurotrophic factor GDNF promotes survival of salivary stem cells. Journal of Clinical Investigation, 124(8), 3364–77.
- Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema
  Binkley, M. S., Shrager, J. B., Leung, A. N., Popat, R., Trakul, N., Atwood, T. F., … Loo, B. W. (2014). Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(1), 216–23.
- Pulmonary Ventilation Imaging Based on 4-Dimensional Computed Tomography: Comparison With Pulmonary Function Tests and SPECT Ventilation Images
  Yamamoto, T., Kabus, S., Lorenz, C., Mittra, E., Hong, J. C., Chung, M., … Keall, P. J. (2014). Pulmonary Ventilation Imaging Based on 4-Dimensional Computed Tomography: Comparison With Pulmonary Function Tests and SPECT Ventilation Images. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(2), 414–22.
- Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response
  Kuo, P., Bratman, S. V., Shultz, D. B., von Eyben, R., Chan, C., Wang, Z., … Quynh-Thu Le, Q. T. (2014). Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response. CLINICAL CANCER RESEARCH, 20(21), 5558–69.
- FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution
  Newman, A. M., Bratman, S. V., Stehr, H., Lee, L. J., Liu, C. L., Diehn, M., & Alizadeh, A. A. (2014). FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution. BIOINFORMATICS, 30(23), 3390–93.
- Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq.
  Bratman, S. V., Newman, A. M., Alizadeh, A. A., & Diehn, M. (2015). Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq. Expert Review of Molecular Diagnostics, 1–5.
- Identification and genetic manipulation of human and mouse oesophageal stem cells.
  Jeong, Y., Rhee, H., Martin, S., Klass, D., Lin, Y., Nguyen, L. X. T., … Diehn, M. (2016). Identification and genetic manipulation of human and mouse oesophageal stem cells. Gut, 65(7), 1077–86.
- To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
  Shultz, D. B., Diehn, M., & Loo, B. W. (2015). To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer. SEMINARS IN RADIATION ONCOLOGY, 25(2), 78–86.
- Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D
  Jeong, Y., Swami, S., Krishnan, A. V., Williams, J. D., Martin, S., Horst, R. L., … Diehn, M. (2015). Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D. MOLECULAR CANCER THERAPEUTICS, 14(8), 1951–61.
- Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.
  Kurtz, D. M., Green, M. R., Bratman, S. V., Scherer, F., Liu, C. L., Kunder, C. A., … Alizadeh, A. A. (2015). Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood, 125(24), 3679–87.
- Robust enumeration of cell subsets from tissue expression profiles.
  Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., … Alizadeh, A. A. (2015). Robust enumeration of cell subsets from tissue expression profiles. Nature Methods, 12(5), 453–57.
- Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
  Chaudhuri, A. A., Tang, C., Binkley, M. S., Jin, M., Wynne, J. F., von Eyben, R., … Diehn, M. (2015). Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. LUNG CANCER, 89(1), 50–56.
- Analysis of Long-Term 4-Dimensional Computed Tomography Regional Ventilation After Radiation Therapy
  King, M. T., Maxim, P. G., Diehn, M., Loo, B. W., & Xing, L. (2015). Analysis of Long-Term 4-Dimensional Computed Tomography Regional Ventilation After Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(3), 683–90.
- Noninvasive pulmonary nodule elastometry by CT and deformable image registration.
  Negahdar, M., Fasola, C. E., Yu, A. S., von Eyben, R., Yamamoto, T., Diehn, M., … Maxim, P. G. (2015). Noninvasive pulmonary nodule elastometry by CT and deformable image registration. Radiotherapy and Oncology , 115(1), 35–40.
- Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors.
  Harris, J. P., Chang-Halpenny, C. N., Maxim, P. G., Quon, A., Graves, E. E., Diehn, M., & Loo, B. W. (2015). Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors. Clinical Lung Cancer, 16(6), 475–85.
- Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
  Binkley, M. S., Trakul, N., Jacobs, L. R., von Eyben, R., Quynh-Thu Le, Q. T., Maxim, P. G., … Diehn, M. (2015). Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(5), 1044–52.
- The prognostic landscape of genes and infiltrating immune cells across human cancers
  Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., … Alizadeh, A. A. (2015). The prognostic landscape of genes and infiltrating immune cells across human cancers. NATURE MEDICINE, 21(8), 938–45.
- Anatomic optimization of lung tumor stereotactic ablative radiation therapy.
  Yu, A. S., von Eyben, R., Yamamoto, T., Diehn, M., Shultz, D. B., Loo, B. W., & Maxim, P. G. (2015). Anatomic optimization of lung tumor stereotactic ablative radiation therapy. Practical Radiation Oncology, 5(6), e607–13.
- Noninvasive pulmonary nodule elastometry by CT and deformable image registration
  Negandar, M., Fasola, C. E., Yu, A. S., von Eyben, R., Yamamoto, T., Diehn, M., … Maxim, P. G. (2015). Noninvasive pulmonary nodule elastometry by CT and deformable image registration. RADIOTHERAPY AND ONCOLOGY, 115(1), 35–40.
- TU-AB-201-06: Evaluation of Electromagnetically Guided High- Dose Rate Brachytherapy for Ablative Treatment of Lung Metastases.
  Pinkham, D. W., Shultz, D., Loo, B. W., Sung, A., Diehn, M., & Fahimian, B. P. (2015). TU-AB-201-06: Evaluation of Electromagnetically Guided High- Dose Rate Brachytherapy for Ablative Treatment of Lung Metastases. Medical Physics, 42(6), 3595-?
- Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.
  Gentles, A. J., Bratman, S. V., Lee, L. J., Harris, J. P., Feng, W., Nair, R. V., … Diehn, M. (2015). Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. Journal of the National Cancer Institute, 107(10).
- Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial
  Westover, K. D., Loo, B. W., Gerber, D. E., Iyengar, P., Choy, H., Diehn, M., … Timmerman, R. (2015). Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(1), 72–81.
- Robust enumeration of cell subsets from tissue expression profiles
  Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., … Alizadeh, A. A. (2015). Robust enumeration of cell subsets from tissue expression profiles. NATURE METHODS, 12(5), 453-?
- Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.
  Binkley, M. S., Shrager, J. B., Leung, A. N., Popat, R., Trakul, N., Atwood, T. F., … Loo, B. W. (2014). Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema. International Journal of Radiation Oncology, Biology, Physics, 90(1), 216–23.
- Pulmonary ventilation imaging based on 4-dimensional computed tomography: comparison with pulmonary function tests and SPECT ventilation images.
  Yamamoto, T., Kabus, S., Lorenz, C., Mittra, E., Hong, J. C., Chung, M., … Keall, P. J. (2014). Pulmonary ventilation imaging based on 4-dimensional computed tomography: comparison with pulmonary function tests and SPECT ventilation images. International Journal of Radiation Oncology, Biology, Physics, 90(2), 414–22.
- To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer.
  Shultz, D. B., Diehn, M., & Loo, B. W. (2015). To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer. Seminars in Radiation Oncology, 25(2), 78–86.
- Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial.
  Westover, K. D., Loo, B. W., Gerber, D. E., Iyengar, P., Choy, H., Diehn, M., … Timmerman, R. (2015). Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial. International Journal of Radiation Oncology, Biology, Physics, 93(1), 72–81.
- Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.
  Chaudhuri, A. A., Binkley, M. S., Osmundson, E. C., Alizadeh, A. A., & Diehn, M. (2015). Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. Seminars in Radiation Oncology, 25(4), 305–12.
- Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.
  Gentles, A. J., Bratman, S. V., Lee, L. J., Harris, J. P., Feng, W., Nair, R. V., … Diehn, M. (2015). Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. Journal of the National Cancer Institute, 107(10).
- Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.
  Myall, N. J., Neal, J. W., Cho-Phan, C. D., Zhou, L. Y., Stehr, H., Zhou, L., … Wakelee, H. A. (2016). Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene. Clinical Lung Cancer, 17(2), e17–21.
- Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
  Binkley, M. S., Hiniker, S. M., Chaudhuri, A., Maxim, P. G., Diehn, M., Loo, B. W., & Shultz, D. B. (2016). Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation. International Journal of Radiation Oncology, Biology, Physics, 94(4), 808–15.
- Molecular Determinants of Radiation Response in Non-Small Cell Lung Cancer
  Yom, S. S., Diehn, M., & Raben, D. (2015). Molecular Determinants of Radiation Response in Non-Small Cell Lung Cancer. SEMINARS IN RADIATION ONCOLOGY, 25(2), 67–77.
- Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors.
  Binkley, M. S., Shrager, J. B., Chaudhuri, A., Popat, R., Maxim, P. G., Shultz, D. B., … Loo, B. W. (2016). Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors. Radiation Oncology , 11(1), 40-?
- 3D Riesz-wavelet based Covariance descriptors for texture classification of lung nodule tissue in CT.
  Cirujeda, P., Muller, H., Rubin, D., Aguilera, T. A., Loo, B. W., Diehn, M., … Depeursinge, A. (2015). 3D Riesz-wavelet based Covariance descriptors for texture classification of lung nodule tissue in CT. Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference, 2015, 7909–12.
- Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis.
  Wu, J., Aguilera, T., Shultz, D., Gudur, M., Rubin, D. L., Loo, B. W., … Li, R. (2016). Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis. Radiology, 281(1), 270–78.
- Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
  Binkley, M. S., Shrager, J. B., Chaudhuri, A., Popat, R., Maxim, P. G., Shultz, D. B., … Loo, B. W. (2016). Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors. RADIATION ONCOLOGY, 11.
- Integrated digital error suppression for improved detection of circulating tumor DNA
  Newman, A. M., Lovejoy, A. F., Klass, D. M., Kurtz, D. M., Chabon, J. J., Scherer, F., … Alizadeh, A. A. (2016). Integrated digital error suppression for improved detection of circulating tumor DNA. NATURE BIOTECHNOLOGY, 34(5), 547–55.
- Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study.
  Wu, J., Gensheimer, M. F., Dong, X., Rubin, D. L., Napel, S., Diehn, M., … Li, R. (2016). Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study. International Journal of Radiation Oncology, Biology, Physics, 95(5), 1504–12.
- Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).
  Chaudhuri, A. A., Binkley, M. S., Rigdon, J., Carter, J. N., Aggarwal, S., Dudley, S. A., … Guo, H. H. (2016). Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR). Radiotherapy and Oncology , 119(3), 454–60.
- The impact of audiovisual biofeedback on 4D functional and anatomic imaging: Results of a lung cancer pilot study.
  Yang, J., Yamamoto, T., Pollock, S., Berger, J., Diehn, M., Graves, E. E., … Keall, P. J. (2016). The impact of audiovisual biofeedback on 4D functional and anatomic imaging: Results of a lung cancer pilot study. Radiotherapy and Oncology , 120(2), 267–72.
- Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
  Chabon, J. J., Simmons, A. D., Lovejoy, A. F., Esfahani, M. S., Newman, A. M., Haringsma, H. J., … Diehn, M. (2016). Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. NATURE COMMUNICATIONS, 7.
- Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer.
  Pollom, E. L., Qian, Y., Durkee, B. Y., von Eyben, R., Maxim, P. G., Shultz, D. B., … Loo, B. W. (2016). Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer. Clinical Lung Cancer, 17(6), 588–94.
- Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.
  Jeong, Y., Hoang, N. T., Lovejoy, A., Stehr, H., Newman, A. M., Gentles, A. J., … Diehn, M. (2016). Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Cancer Discovery.
- Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
  Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2016). Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. SCIENCE TRANSLATIONAL MEDICINE, 8(364).
- Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy
  Abelson, J. A., Murphy, J. D., Trakul, N., Bazan, J. G., Maxim, P. G., Graves, E. E., … Loo, B. W. (2012). Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. LUNG CANCER, 78(3), 219–24.
- Identification and genetic manipulation of human and mouse oesophageal stem cells
  Jeong, Y., Rhee, H., Martin, S., Klass, D., Lin, Y., Le Xuan Truong Nguyen, L. X. T., … Diehn, M. (2016). Identification and genetic manipulation of human and mouse oesophageal stem cells. GUT, 65(7), 1077–86.
- Molecular profiling of single circulating tumor cells from lung cancer patients
  Park, S.-M., Wong, D. J., Ooi, C. C., Kurtz, D. M., Vermesh, O., Aalipour, A., … Gambhir, S. S. (2016). Molecular profiling of single circulating tumor cells from lung cancer patients. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113(52), E8379–E8386.
- Control of inflammation by stromal Hedgehog pathway activation restrains colitis.
  Lee, J. J., Rothenberg, M. E., Seeley, E. S., Zimdahl, B., Kawano, S., Lu, W.-J., … Beachy, P. A. (2016). Control of inflammation by stromal Hedgehog pathway activation restrains colitis. Proceedings of the National Academy of Sciences of the United States of America.
- Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung.
  Binkley, M. S., King, M. T., Shrager, J. B., Bush, K., Chaudhuri, A. A., Popat, R., … Loo, B. W. (2017). Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung. Radiotherapy and Oncology , 123(2), 270–75.
- Reprogramming the immunological microenvironment through radiation and targeting Axl
  Aguilera, T. A., Rafat, M., Castellini, L., Shehade, H., Kariolis, M. S., Hui, A. B.-Y., … Giaccia, A. J. (2016). Reprogramming the immunological microenvironment through radiation and targeting Axl. NATURE COMMUNICATIONS, 7.
- ERBB2-Mutated Metastatic Non-Small Cell Lung Cancer: Response and Resistance to Targeted Therapies.
  Chuang, J. C., Stehr, H., Liang, Y., Das, M., Huang, J., Diehn, M., … Neal, J. W. (2017). ERBB2-Mutated Metastatic Non-Small Cell Lung Cancer: Response and Resistance to Targeted Therapies. Journal of Thoracic Oncology .
- Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
  Chabon, J. J., Simmons, A. D., Lovejoy, A. F., Esfahani, M. S., Newman, A. M., Haringsma, H. J., … Diehn, M. (2016). Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nature Communications, 7, 13513-?
- A 3-D Riesz-Covariance Texture Model for Prediction of Nodule Recurrence in Lung CT
  Cirujeda, P., Cid, Y. D., Muller, H., Rubin, D., Aguilera, T. A., Loo, B. W., … Depeursinge, A. (2016). A 3-D Riesz-Covariance Texture Model for Prediction of Nodule Recurrence in Lung CT. IEEE TRANSACTIONS ON MEDICAL IMAGING, 35(12), 2620–30.
- PS01.67: Case Series of MET Exon 14 Skipping Mutation-Positive Non-Small Cell Lung Cancers and Response to Crizotinib: Topic: Medical Oncology.
  Wang, S. X., Zhang, B. M., Wakelee, H., Diehn, M., Kunder, C. A., & Neal, J. W. (2016). PS01.67: Case Series of MET Exon 14 Skipping Mutation-Positive Non-Small Cell Lung Cancers and Response to Crizotinib: Topic: Medical Oncology. Journal of Thoracic Oncology , 11(11S), S312–S313.
- Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance
  Jeong, Y., Hoang, N. T., Lovejoy, A., Stehr, H., Newman, A. M., Gentles, A. J., … Diehn, M. (2017). Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. CANCER DISCOVERY, 7(1), 86–101.
- Normal Tissue Constraints for Abdominal and Thoracic Stereotactic Body Radiotherapy.
  Pollom, E. L., Chin, A. L., Diehn, M., Loo, B. W., & Chang, D. T. (2017). Normal Tissue Constraints for Abdominal and Thoracic Stereotactic Body Radiotherapy. Seminars in Radiation Oncology, 27(3), 197–208.
- Case Series of MET Exon 14 Skipping Mutation-positive Non-Small Cell Lung Cancers and Response to Crizotinib.
  Wang, S. X., Zhang, B., Wakelee, H. A., Diehn, M., Kunder, C., & Neal, J. W. (2017). Case Series of MET Exon 14 Skipping Mutation-positive Non-Small Cell Lung Cancers and Response to Crizotinib. International Journal of Radiation Oncology, Biology, Physics, 98(1), 239-?
- Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA.
  Offin, M., Chabon, J. J., Razavi, P., Isbell, J. M., Rudin, C. M., Diehn, M., & Li, B. T. (2017). Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA. Journal of Oncology, 2017, 4517834-?
- Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors.
  Qian, Y., Zhu, H., Pollom, E. L., Durkee, B. Y., Chaudhuri, A. A., Gensheimer, M. F., … Loo, B. W. (2017). Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors. Practical Radiation Oncology.
- Data normalization considerations for digital tumor dissection.
  Newman, A. M., Gentles, A. J., Liu, C. L., Diehn, M., & Alizadeh, A. A. (2017). Data normalization considerations for digital tumor dissection. Genome Biology, 18(1), 128.
- SU-D-207B-05: Robust Intra-Tumor Partitioning to Identify High-Risk Subregions for Prognosis in Lung Cancer.
  Wu, J., Gensheimer, M., Dong, X., Rubin, D., Napel, S., Diehn, M., … Li, R. (2016). SU-D-207B-05: Robust Intra-Tumor Partitioning to Identify High-Risk Subregions for Prognosis in Lung Cancer. Medical Physics, 43(6), 3349-?
- Intratumor Partitioning of Serial Computed Tomography and FDG Positron Emission Tomography Images Identifies High-Risk Tumor Subregions and Predicts Patterns of Failure in Non-Small Cell Lung Cancer After Radiation Therapy
  Wu, J., Gensheimer, M. F., Dong, X., Rubin, D. L., Napel, S., Diehn, M., … Li, R. (2016). Intratumor Partitioning of Serial Computed Tomography and FDG Positron Emission Tomography Images Identifies High-Risk Tumor Subregions and Predicts Patterns of Failure in Non-Small Cell Lung Cancer After Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), S100–S100.
- Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma
  Scherer, F., Kurtz, D. M., Newman, A. M., Esfahani, M. S., Craig, A., Stehr, H., … Alizadeh, A. A. (2016). Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma. BLOOD. SAN DIEGO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: AMER SOC HEMATOLOGY.
- Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC.
  Lee, J., Cui, Y., Sun, X., Li, B., Wu, J., Li, D., … Li, R. (2017). Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC. European Radiology.
- Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling.
  Chaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., … Diehn, M. (2017). Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discovery.
- Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA.
  Aalipour, A., Dudley, J. C., Park, S.-M. M., Murty, S., Chabon, J. J., Boyle, E. A., … Gambhir, S. S. (2017). Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA. Clinical Chemistry.
- Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
  Li, B., Cui, Y., Diehn, M., & Li, R. (2017). Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer. JAMA Oncology.
- Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease.
  Rhee, S., Chung, J. I., King, D. A., D'amato, G., Paik, D. T., Duan, A., … Red-Horse, K. (2018). Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease. Nature Communications, 9(1), 368.
- Combination approach for detecting different types of alterations in circulating tumor DNA in leiomyosarcoma.
  Przybyl, J., Chabon, J. J., Spans, L., Ganjoo, K., Vennam, S., Newman, A. M., … van de Rijn, M. (2018). Combination approach for detecting different types of alterations in circulating tumor DNA in leiomyosarcoma. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Genomic feature selection by coverage design optimization
  Reid, S., Newman, A. M., Diehn, M., Alizadeh, A. A., & Tibshirani, R. (2018). Genomic feature selection by coverage design optimization. Journal of Applied Statistics.
- Noninvasive Pulmonary Nodule Elastometry by CT and Deformable Image Registration
  Negahdar, M., Shultz, D. B., Eyben, R. V., Fasola, C., Yu, A. S., Tian, L., … Maxim, P. G. (2014). Noninvasive Pulmonary Nodule Elastometry by CT and Deformable Image Registration. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S623–S624.
- Noninvasive Pulmonary Nodule Elastometry by CT and Deformable Image Registration
  Negahdar, M., Shultz, D. B., Eyben, R. V., Fasola, C., Yu, A. S., Tian, L., … Maxim, P. G. (2014). Noninvasive Pulmonary Nodule Elastometry by CT and Deformable Image Registration. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S10.
- A Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery (SRS) for Large Resection Cavities of Brain Metastases
  Soltys, S. G., Seiger, K., Modlin, L. A., Gibbs, I. C., Hara, W., Kidd, E. A., … Choi, C. Y. H. (2015). A Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery (SRS) for Large Resection Cavities of Brain Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Comparison of Circulating Tumor DNA Analysis and Surveillance Imaging After Treatment for Localized Lung Cancer
  Chaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A., Stehr, H., Azad, T. D., … Diehn, M. (2017). Comparison of Circulating Tumor DNA Analysis and Surveillance Imaging After Treatment for Localized Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Analysis of Circulating Tumor DNA in Esophageal Carcinoma Patients Treated With Chemoradiation Therapy
  Klass, D., Newman, A., Lovejoy, A. F., Zhou, L., Stehr, H., Xu, T., … Diehn, M. (2015). Analysis of Circulating Tumor DNA in Esophageal Carcinoma Patients Treated With Chemoradiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), S104–S105.
- Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing
  Diehn, M., Bratman, S. V., Newman, A. M., Neal, J. W., Wakelee, H. A., Merritt, R. E., … Alizadeh, A. (2014). Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Circulating Tumor DNA Analysis during Radiation Therapy for Localized Lung Cancer Predicts Treatment Outcome
  Chaudhuri, A. A., Lovejoy, A. F., Chabon, J. J., Newman, A., Stehr, H., Merriott, D. J., … Diehn, M. (2017). Circulating Tumor DNA Analysis during Radiation Therapy for Localized Lung Cancer Predicts Treatment Outcome. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Circulating Tumor DNA Concentrations Reflect Metabolic Tumor Volume in NSCLC
  Modlin, L. A., Bratman, S. V., Newman, A. M., Eclov, N. C. W., Neal, J. W., Wakelee, H. A., … Diehn, M. (2014). Circulating Tumor DNA Concentrations Reflect Metabolic Tumor Volume in NSCLC. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer
  Chaudhuri, A. A., Lovejoy, A. F., Chabon, J. J., Newman, A., Stehr, H., Say, C., … Diehn, M. (2016). CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Circulating Tumor DNA as a Biomarker for Pancreatic Adenocarcinoma
  Osmundson, E., Newman, A. M., Bratman, S. V., Klass, D. M., Zhou, L., Pai, J., … Diehn, M. (2014). Circulating Tumor DNA as a Biomarker for Pancreatic Adenocarcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S816–S817.
- Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Lung Cancer
  Merriott, D. J., Chaudhuri, A. A., Jin, M., Chabon, J. J., Newman, A., Stehr, H., … Diehn, M. (2017). Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Pretreatment Circulating Tumor DNA for Risk Stratification of Locally Advanced Esophageal Cancer Treated With Chemoradiation and Surgery
  Azad, T. D., Chaudhuri, A. A., Newman, A., Stehr, H., Schroers-Martin, J., Chabon, J. J., … Diehn, M. (2017). Pretreatment Circulating Tumor DNA for Risk Stratification of Locally Advanced Esophageal Cancer Treated With Chemoradiation and Surgery. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99(2), S90–S91.
- Noninvasive and Ultrasensitive Quantitation of Circulating Tumor DNA by Hybrid Capture and Deep Sequencing
  Bratman, S. V., Newman, A. M., To, J., Wynne, J. F., Neal, J. W., Wakelee, H., … Diehn, M. (2013). Noninvasive and Ultrasensitive Quantitation of Circulating Tumor DNA by Hybrid Capture and Deep Sequencing. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Circulating tumor DNA testing in advanced non-small cell lung cancer.
  Moding, E. J., Diehn, M., & Wakelee, H. A. (2018). Circulating tumor DNA testing in advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands), 119, 42–47.
- Safety and Efficacy of Stereotactic Ablative Radiotherapy (SABR) to Multiple (3 or More) Lung Tumors
  Moding, E. J., Maxim, P. G., Diehn, M., Loo, B. W., & Gensheimer, M. F. (2017). Safety and Efficacy of Stereotactic Ablative Radiotherapy (SABR) to Multiple (3 or More) Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99(2), E482.
- Mid-radiation Therapy PET/CT for Prognostication and Detection of Early Progression in Patients With Stage III Non-small Cell Lung Cancer
  Gensheimer, M. F., Hong, J. C., Chang-Halpenny, C. N., Eclov, N., To, J., Murphy, J. D., … Loo, B. W. (2017). Mid-radiation Therapy PET/CT for Prognostication and Detection of Early Progression in Patients With Stage III Non-small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99(2), E456.
- Anatomic and Metabolic Predictors of Failure After Stereotactic Ablative Radiation Therapy for Non-small Cell Lung Cancer
  Shultz, D. B., Trakul, N., Abelson, J. A., Murphy, J. D., Lee, Q. T., Loo, B. W., & Diehn, M. (2012). Anatomic and Metabolic Predictors of Failure After Stereotactic Ablative Radiation Therapy for Non-small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(3), S571–S572.
- Improved Outcomes in Stage I NSCLC Patients Treated in the Stereotactic Ablative Radiation Therapy Era: A Population-based Analysis
  Trakul, N., Murphy, J. D., Loo, B. W., & Diehn, M. (2012). Improved Outcomes in Stage I NSCLC Patients Treated in the Stereotactic Ablative Radiation Therapy Era: A Population-based Analysis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(3), S608.
- A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer.
  Lee, J., Li, B., Cui, Y., Sun, X., Wu, J., Zhu, H., … Li, R. (2018). A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics.
- Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers.
  Blakely, C. M., Watkins, T. B., Wu, W., Gini, B., Chabon, J. J., McCoach, C. E., … Bivona, T. G. (2017). Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers. Nature Genetics, 49(12), 1693–1704.
- The Future of Radiobiology
  Kirsch, D. G., Diehn, M., Kesarwala, A. H., Maity, A., Morgan, M. A., Schwarz, J. K., … Bernhard, E. J. (2018). The Future of Radiobiology. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 110(4), 329–40.
- The prognostic landscape of genes and infiltrating immune cells across human cancers
  Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., … Alizadeh, A. A. (2015). The prognostic landscape of genes and infiltrating immune cells across human cancers. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
  Chin, A. L., Kumar, K. A., Guo, H. H., Maxim, P. G., Wakelee, H., Neal, J. W., … Gensheimer, M. F. (2018). Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer. Clinical Lung Cancer.
- Pre-treatment circulating tumor DNA as a biomarker for disease burden in diffuse large B cell lymphoma (DLBCL)
  Scherer, F., Kurtz, D. M., Green, M. R., Newman, A. M., Klass, D. M., Zhou, L., … Alizadeh, A. A. (2015). Pre-treatment circulating tumor DNA as a biomarker for disease burden in diffuse large B cell lymphoma (DLBCL). JOURNAL OF CLINICAL ONCOLOGY, 33(15).
- Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma
  Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Liu, C. L., Zhou, L., … Alizadeh, A. A. (2015). Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma. BLOOD. AMER SOC HEMATOLOGY.
- Noninvasive monitoring of cellular versus acellular tumor DNA from immunoglobulin genes for DLBCL.
  Kurtz, D. M., Green, M. R., Bratman, S. V., Liu, C.-L., Glover, C., Keane, C., … Alizadeh, A. A. (2014). Noninvasive monitoring of cellular versus acellular tumor DNA from immunoglobulin genes for DLBCL. JOURNAL OF CLINICAL ONCOLOGY, 32(15).
- Distinct early response dynamics of circulating tumor DNA and circulating tumor cells during therapy of B-cell NHL.
  Kurtz, D. M., Scherer, F., Green, M. R., Khodadoust, M. S., Klass, D. M., Zhou, L., … Alizadeh, A. A. (2015). Distinct early response dynamics of circulating tumor DNA and circulating tumor cells during therapy of B-cell NHL. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer
  Gensheimer, M. F., Hong, J. C., Chang-Halpenny, C., Zhu, H., Eclov, N. C. W., To, J., … Loo, B. W. (2017). Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer. RADIOTHERAPY AND ONCOLOGY, 125(2), 338–43.
- Outcomes of Moderately Hypofractionated Intensity-Modulated Thoracic Radiotherapy with Concurrent Chemotherapy for Treatment of Non-Small Cell Lung Cancer
  Xiang, M., Gensheimer, M. F., Maxim, P. G., Wakelee, H. A., Neal, J. W., Diehn, M., & Loo, B. W. (2017). Outcomes of Moderately Hypofractionated Intensity-Modulated Thoracic Radiotherapy with Concurrent Chemotherapy for Treatment of Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99(2), E504.
- Noninvasive and ultrasensitive quantitation of circulating tumor DNA by hybrid capture and deep sequencing.
  Bratman, S. V., Newman, A. M., To, J., Wynne, J. F., Neal, J. W., Wakelee, H. A., … Alizadeh, A. A. (2014). Noninvasive and ultrasensitive quantitation of circulating tumor DNA by hybrid capture and deep sequencing. JOURNAL OF CLINICAL ONCOLOGY, 32(15).
- Circulating Tumor DNA Detects Residual Disease and Anticipates Tumor Progression Earlier Than CT Imaging
  Chaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., … Diehn, M. (2017). Circulating Tumor DNA Detects Residual Disease and Anticipates Tumor Progression Earlier Than CT Imaging. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 98(2), E4.
- Dynamic Noninvasive Genomic Monitoring for Outcome Prediction in Diffuse Large B-Cell Lymphoma
  Kurtz, D. M., Scherer, F., Newman, A. M., Lovejoy, A. F., Klass, D. M., Chabon, J. J., … Alizadeh, A. A. (2015). Dynamic Noninvasive Genomic Monitoring for Outcome Prediction in Diffuse Large B-Cell Lymphoma. BLOOD, 126(23).
- 18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy.
  Qian, Y., Von Eyben, R., Liu, Y., Chin, F. T., Miao, Z., Apte, S., … Loo, B. W. (2018). 18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics.
- Patterns of Failure After Hypofractionated Intensity Modulated Radiation Therapy for Patients With Non-Small Cell Lung Cancer
  Qian, Y., Pollom, E., Durkee, B. Y., von Eyben, R., Gensheimer, M. F., Shultz, D. B., … Loo, B. W. (2016). Patterns of Failure After Hypofractionated Intensity Modulated Radiation Therapy for Patients With Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E422–E423.
- 18F-EF5 Pet-Based Imageable Hypoxia Predicts for Local Control in Tumors Treated With Conformal Radiotherapy
  Qian, Y., Liu, Y., Von Eyben, R., Carter, J. N., Pollom, E. L., Harris, J. P., … Loo, B. W. (2018). 18F-EF5 Pet-Based Imageable Hypoxia Predicts for Local Control in Tumors Treated With Conformal Radiotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- GFPT2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma.
  Zhang, W., Bouchard, G., Yu, A., Shafiq, M., Jamali, M., Shrager, J. B., … Plevritis, S. K. (2018). GFPT2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma. Cancer Research.
- Circulating tumor DNA levels correlate with response to treatment in LMS patients
  Przybyl, J., Chabon, J. J., Spans, L., Ganjoo, K., Vennam, S., Newman, A. M., … van de Rijn, M. (2018). Circulating tumor DNA levels correlate with response to treatment in LMS patients. CLINICAL CANCER RESEARCH, 24(2), 38–39.
- Line-Enhanced Deformable Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy With Radiation-Induced Fibrosis.
  King, M., Sensakovic, W. F., Maxim, P., Diehn, M., Loo, B. W., & Xing, L. (2018). Line-Enhanced Deformable Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy With Radiation-Induced Fibrosis. Technology in Cancer Research & Treatment, 17, 1533034617749419.
- Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Metastatic Non-Small Cell Lung Cancer
  Chaudhuri, A. A., Nabet, B. Y., Merriott, D. J., Jin, M., Chen, E. L., Chabon, J. J., … Diehn, M. (2018). Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Metastatic Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- A Feasibility Study of Single-inhalation, Single-energy Xenon-enhanced CT for High-resolution Imaging of Regional Lung Ventilation in Humans.
  Pinkham, D. W., Negahdar, M., Yamamoto, T., Mittra, E., Diehn, M., Nair, V. S., … Loo, B. W. (2018). A Feasibility Study of Single-inhalation, Single-energy Xenon-enhanced CT for High-resolution Imaging of Regional Lung Ventilation in Humans. Academic Radiology.
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
  Merker, J. D., Oxnard, G. R., Compton, C., Diehn, M., Hurley, P., Lazar, A. J., … Turner, N. C. (2018). Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(16), 1631–41.
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
  Merker, J. D., Oxnard, G. R., Compton, C., Diehn, M., Hurley, P., Lazar, A. J., … Turner, N. C. (2018). Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Archives of Pathology & Laboratory Medicine.
- Comprehensive Analysis of the Unfolded Protein Response in Breast Cancer Subtypes.
  Jiang, D., Turner, B., Song, J., Li, R., Diehn, M., Le, Q.-T., … Koong, A. C. (2017). Comprehensive Analysis of the Unfolded Protein Response in Breast Cancer Subtypes. JCO Precision Oncology, 2017.
- MID-RADIATION THERAPY PET CORRELATES WITH SURVIVAL IN LOCALLY ADVANCED NSCLC
  Loo, B. W., Chang, C., Hong, J., Wakelee, H., Quynh Thu Le, Hara, W. Y., … Olson, M. (2011). MID-RADIATION THERAPY PET CORRELATES WITH SURVIVAL IN LOCALLY ADVANCED NSCLC. JOURNAL OF THORACIC ONCOLOGY, 6(6), S694–S695.
- A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer
  Harris, J. P., Patel, M. I., Loo, B. W., Wakelee, H. A., & Diehn, M. (2017). A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer. LUNG CANCER, 108, 173–82.
- High-throughput sequencing for noninvasive disease detection in hematologic malignancies.
  Scherer, F., Kurtz, D. M., Diehn, M., & Alizadeh, A. A. (2017). High-throughput sequencing for noninvasive disease detection in hematologic malignancies. Blood, 130(4), 440–52.
- Interim results of a randomized trial of observation versus SABR for oligometastatic prostate cancer
  Tran, P., Radwan, N., Phillips, R., Ross, A., Rowe, S., Gorin, M., … Eisenberger, M. (2018). Interim results of a randomized trial of observation versus SABR for oligometastatic prostate cancer. RADIOTHERAPY AND ONCOLOGY, 127, S261.
- Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.
  Kurtz, D. M., Scherer, F., Jin, M. C., Soo, J., Craig, A. F., Esfahani, M. S., … Alizadeh, A. A. (2018). Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2018785246.
- Patterns of Care and Health Disparities for Patients With Stage I Non-small Cell Lung Cancer in the US
  Harris, J. P., Nwachukwu, C. R., Loo, B. W., Das, M., & Diehn, M. (2017). Patterns of Care and Health Disparities for Patients With Stage I Non-small Cell Lung Cancer in the US. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99(2), E399.
- Novel Lung Ventilation Imaging with Single Energy CT After Single Inhalation of Xenon: Comparison with SPECT Ventilation Images
  Negahdar, M., Yamamoto, T., Shultz, D., Gable, L., Shan, X., Mittra, E., … Maxim, P. (2014). Novel Lung Ventilation Imaging with Single Energy CT After Single Inhalation of Xenon: Comparison with SPECT Ventilation Images. MEDICAL PHYSICS, 41(6), 450.
- Noninvasive Cancer Classification Using Diverse Genomic Features in Circulating Tumor DNA
  Esfahani, M. S., Newman, A. M., Scherer, F., Tibshirani, R., Diehn, M., & Alizadeh, A. A. (2016). Noninvasive Cancer Classification Using Diverse Genomic Features in Circulating Tumor DNA. PROCEEDINGS OF THE 7TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, 516.
- Deep sequencing of circulating tumor DNA for personalized lung cancer detection and radiotherapy response monitoring
  Diehn, M. (2016). Deep sequencing of circulating tumor DNA for personalized lung cancer detection and radiotherapy response monitoring. JOURNAL OF THORACIC ONCOLOGY, 11(2), S3.
- Practical workflow for rapid prototyping of radiation therapy positioning devices
  Gensheimer, M. F., Bush, K., Juang, T., Herzberg, B., Villegas, M., Maxim, P. G., … Loo, B. W. (2017). Practical workflow for rapid prototyping of radiation therapy positioning devices. PRACTICAL RADIATION ONCOLOGY, 7(6), 442–45.
- Radiogenomic Analysis of a Peritumoral CT Image Feature and Its Prognostic Value in Early Stage NSCLC
  Lee, J., Cui, Y., Gensheimer, M. F., Loo, B. W., Diehn, M., & Li, R. (2017). Radiogenomic Analysis of a Peritumoral CT Image Feature and Its Prognostic Value in Early Stage NSCLC. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99(2), S48.
- Validation of Temporal Change in Quantitative PET Metrics as Predictors of Recurrence in Early Stage Lung Cancer Patients Treated With SABR
  Prionas, N. D., Yi, E., Aggarwal, S., Shaffer, J., Von Eyben, R., Graves, E. E., … Loo, B. W. (2017). Validation of Temporal Change in Quantitative PET Metrics as Predictors of Recurrence in Early Stage Lung Cancer Patients Treated With SABR. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 99(2), S18–S19.
- Randomized Phase Phase II Study of Preoperative Chemoradiotherapy +/- Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIla, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839
  Edelman, M. J., Hu, C., Quynh-Thu Le, Donington, J. S., D'Souza, W. D., Dicker, A. P., … Bradley, J. D. (2017). Randomized Phase Phase II Study of Preoperative Chemoradiotherapy +/- Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIla, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. JOURNAL OF THORACIC ONCOLOGY, 12(9), 1413–20.
- A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
  Radwan, N., Phillips, R., Ross, A., Rowe, S. P., Gorin, M. A., Antonarakis, E. S., … Tran, P. T. (2017). A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE). BMC CANCER, 17, 453.
- Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer Tumors Greater Than 5 cm
  Anderson, E. M., Sharma, A., Westover, K. D., Timmerman, R., von Eyben, R., Gensheimer, M. F., … Shultz, D. B. (2017). Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer Tumors Greater Than 5 cm. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Absence of Evidence Implicating Hematopoietic Stem Cells As Common Progenitors for DLBCL Mutations
  Jan, M., Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Liu, C. L., … Alizadeh, A. A. (2016). Absence of Evidence Implicating Hematopoietic Stem Cells As Common Progenitors for DLBCL Mutations. BLOOD. AMER SOC HEMATOLOGY.
- Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
  Kurtz, D. M., Scherer, F., Newman, A. M., Craig, A., Jin, M., Stehr, H., … Alizadeh, A. A. (2016). Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma. BLOOD. AMER SOC HEMATOLOGY.
- Noninvasive Detection of Ibrutinib Resistance in Non-Hodgkin Lymphoma Using Cell-Free DNA
  Scherer, F., Kurtz, D. M., Newman, A. M., Craig, A., Stehr, H., Zhou, L., … Alizadeh, A. A. (2016). Noninvasive Detection of Ibrutinib Resistance in Non-Hodgkin Lymphoma Using Cell-Free DNA. BLOOD, 128(22).
- Predictive Modeling of Outcome Following SABR for NSCLC Based On Radiomics of FDG-PET Images
  Li, R., Aguilera, T., Shultz, D., Rubin, D., Diehn, M., & Loo, B. (2014). Predictive Modeling of Outcome Following SABR for NSCLC Based On Radiomics of FDG-PET Images. MEDICAL PHYSICS, 41(6).
- Vesselness-Based Deformable Registration Algorithms Can Reduce Landmark Errors in the Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy
  King, M., Xiong, G., Maxim, P. G., Diehn, M., Loo, B. W., & Xing, L. (2016). Vesselness-Based Deformable Registration Algorithms Can Reduce Landmark Errors in the Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), S227.
- Role of Surveillance Imaging Versus Symptoms and Signs in Detection of Recurrence of Non-Small Cell Lung Cancer After Curative Intent Therapy
  Waliany, S., Shultz, D. B., Gensheimer, M. F., Loo, B. W., & Diehn, M. (2016). Role of Surveillance Imaging Versus Symptoms and Signs in Detection of Recurrence of Non-Small Cell Lung Cancer After Curative Intent Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), S155.
- Imaging Features Associated With Disease Progression After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Multi-Institutional Pooled Analysis
  Anderson, E., Filippi, A. R., Badellino, S., Ricardi, U., von Eyben, R., Gensheimer, M. F., … Shultz, D. B. (2016). Imaging Features Associated With Disease Progression After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Multi-Institutional Pooled Analysis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E485–E486.
- Regional Ventilation Predicts Change in Pulmonary Function After Stereotactic Ablative Radiation Therapy of Lung Tumors
  Binkley, M. S., King, M., Bush, K., Shrager, J. B., Chaudhuri, A. A., Popat, R., … Loo, B. W. (2016). Regional Ventilation Predicts Change in Pulmonary Function After Stereotactic Ablative Radiation Therapy of Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E456–E457.
- Temporal Change in Quantitative Positron Emission Tomography Metrics Predicts Recurrence in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy
  Prionas, N. D., Aggarwal, S., Shaffer, J., von Eyben, R., Graves, E. E., Maxim, P. G., … Loo, B. W. (2016). Temporal Change in Quantitative Positron Emission Tomography Metrics Predicts Recurrence in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E457.
- Four-Dimensional Computed Tomography Pulmonary Nodule Elastometry as a Predictor of Regional Recurrence Following Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
  Shaffer, J., Negahdar, M., von Eyben, R., Diehn, M., Maxim, P. G., & Loo, B. W. (2016). Four-Dimensional Computed Tomography Pulmonary Nodule Elastometry as a Predictor of Regional Recurrence Following Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E460.
- Effectiveness of Radiation Therapy for Low- to Intermediate-Grade Neuroendocrine Tumors
  Carter, J. N., Aggarwal, S., Radish, K., Allen, J. R., Koong, A. C., Chang, D. T., … Gensheimer, M. F. (2016). Effectiveness of Radiation Therapy for Low- to Intermediate-Grade Neuroendocrine Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), E202–E203.
- Circulating tumor DNA analysis for liquid biopsies: Current status and future opportunities
  Diehn, M. (2016). Circulating tumor DNA analysis for liquid biopsies: Current status and future opportunities. CANCER RESEARCH, 76.
- Characterizing a new population of adult mouse submandibular gland stem cells
  Xiao, N., Lin, Y., Diehn, M., & Quynh-Thu Le. (2012). Characterizing a new population of adult mouse submandibular gland stem cells. CANCER RESEARCH, 72.
- A let-7 signaling pathway targets metastatic genes enriched in tumor initiating cells
  Frankenberger, C. A., Yun, J., Eves, E. M., Diehn, M., Minn, A. J., & Rosner, M. R. (2012). A let-7 signaling pathway targets metastatic genes enriched in tumor initiating cells. CANCER RESEARCH, 72.
- Pretreatment FDG Uptake of Non-Target Lung Tissue is Significantly Associated With Radiation Pneumonitis Following Stereotactic Ablative Radiation Therapy (SABR)
  Chaudhuri, A., Binkley, M. S., Carter, J. N., Aggarwal, S., Maxim, P. G., Shultz, D. B., … Loo, B. W. (2015). Pretreatment FDG Uptake of Non-Target Lung Tissue is Significantly Associated With Radiation Pneumonitis Following Stereotactic Ablative Radiation Therapy (SABR). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), S150–S151.
- Regional Failure After Stereotactic Ablative Radiation Therapy for Early-Stage Lung Cancer
  Say, C., Diehn, M., Loo, B. W., & Shultz, D. B. (2015). Regional Failure After Stereotactic Ablative Radiation Therapy for Early-Stage Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), E437.
- Acceptable Toxicity Is Observed Following Retreatment of Thoracic Malignancies: Dose Volume Toxicity Data for Repeat Radiation Therapy
  Binkley, M. S., Hiniker, S. M., Maxim, P. G., Diehn, M., Loo, B. W., & Shultz, D. B. (2015). Acceptable Toxicity Is Observed Following Retreatment of Thoracic Malignancies: Dose Volume Toxicity Data for Repeat Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), E429.
- Time Course and Predictive Factors for Lung Volume Reduction Following Stereotactic Ablative Radiation Therapy (SABR) of Lung Tumors
  Binkley, M. S., Shrager, J. B., Chaudhuri, A., Popat, R., Maxim, P. G., Shultz, D. B., … Loo, B. W. (2015). Time Course and Predictive Factors for Lung Volume Reduction Following Stereotactic Ablative Radiation Therapy (SABR) of Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), E424.
- Imaging Based Parameters Associated With Disease Progression of Early-Stage NSCLC Treated With Surgical Resection
  Wang, A., von Eyben, R., Loo, B. W., Diehn, M., Shrager, J. B., Maxim, P. G., … Shultz, D. B. (2015). Imaging Based Parameters Associated With Disease Progression of Early-Stage NSCLC Treated With Surgical Resection. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), E414.
- Preradiation Therapy Metabolic Tumor Growth Rate Predicts Survival and Progression in Patients With Non-Small Cell Lung Cancer
  Wang, A., Diehn, M., Loo, B. W., von Eyben, R., Graves, E. E., Shultz, D. B., & Bazan, J. G. (2015). Preradiation Therapy Metabolic Tumor Growth Rate Predicts Survival and Progression in Patients With Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), E405.
- Deep sequencing of circulating tumor DNA for personalized cancer detection and monitoring
  Diehn, M. (2015). Deep sequencing of circulating tumor DNA for personalized cancer detection and monitoring. ANNALS OF ONCOLOGY, 26, 3.
- The VarScan2's SNVs-Near-Indel Filter: Is It Necessary?
  Suarez, C. J., Stehr, H., Fung, E., Kunder, C. A., Ewalt, M. D., Lal, A., … Zehnder, J. (2015). The VarScan2's SNVs-Near-Indel Filter: Is It Necessary? JOURNAL OF MOLECULAR DIAGNOSTICS. ELSEVIER SCIENCE INC.
- The Impact of Audiovisual Biofeedback On Image Quality During 4D Functional and Anatomic Imaging: Results of a Prospective Clinical Trial
  Keall, P., Yang, J., Yamamoto, T., Pollock, S., Diehn, M., Berger, J., … Loo, B. (2014). The Impact of Audiovisual Biofeedback On Image Quality During 4D Functional and Anatomic Imaging: Results of a Prospective Clinical Trial. MEDICAL PHYSICS, 41(6).
- Increased rates of radiation pneumonitis in patients receiving stereotactic ablative radiotherapy for central versus peripheral lung tumors
  Chaudhuri, A. A., Tang, C., Trakul, N., Wynne, J., Loo, B., & Diehn, M. (2014). Increased rates of radiation pneumonitis in patients receiving stereotactic ablative radiotherapy for central versus peripheral lung tumors. CANCER RESEARCH, 74(19).
- Galectin-1 mediates radiation-related lymphopenia in non-small cell lung cancer and attenuates tumor radiation response
  Kuo, P., Bratman, S., Shultz, D., von Eyben, R., Chan, C., Wang, Z., … Quynh-Thu Le. (2014). Galectin-1 mediates radiation-related lymphopenia in non-small cell lung cancer and attenuates tumor radiation response. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Lung Cancer Stem Cells and Resistance to Radiotherapy
  Bratman, S. V., & Diehn, M. (2014). Lung Cancer Stem Cells and Resistance to Radiotherapy. CANCER STEM CELLS, 173–82.
- Increased Rates of Pneumonitis in Patients Receiving Stereotactic Ablative Radiation Therapy for Central Versus Peripheral Lung Tumors
  Chaudhuri, A., Tang, C., Trakul, N., Wynne, J., Loo, B. W., & Diehn, M. (2014). Increased Rates of Pneumonitis in Patients Receiving Stereotactic Ablative Radiation Therapy for Central Versus Peripheral Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S78–S79.
- Impact of Optimally-Gated PET on Tumor Localization and Quantification
  Lee, K., Loo, B. W., Diehn, M., Atwood, T. F., & Hristov, D. H. (2014). Impact of Optimally-Gated PET on Tumor Localization and Quantification. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S795.
- First in Human High-Resolution Imaging of Regional Lung Function by Single Energy Xenon CT Compared to Ventilation SPECT
  Negahdar, M., Yamamoto, T., Shultz, D. B., Gable, L., Shan, X., Mittra, E., … Loo, B. W. (2014). First in Human High-Resolution Imaging of Regional Lung Function by Single Energy Xenon CT Compared to Ventilation SPECT. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S624.
- Factors Contributing to the Use of Intensity Modulated Versus 3D Conformal Radiation Therapy for Stage III Non-Small Cell Lung Cancer: A SEER-Medicare Study
  Harris, J. P., Loo, B. W., & Diehn, M. (2014). Factors Contributing to the Use of Intensity Modulated Versus 3D Conformal Radiation Therapy for Stage III Non-Small Cell Lung Cancer: A SEER-Medicare Study. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S580.
- Vertebral Fractures After Stereotactic Ablative Radiation Therapy of Lung Tumors
  Aguilera, T. A., Trakul, N., Shultz, D., Maxim, P. G., Diehn, M., & Loo, B. W. (2014). Vertebral Fractures After Stereotactic Ablative Radiation Therapy of Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S160–S161.
- Increased Rates of Pneumonitis in Patients Receiving Stereotactic Ablative Radiation Therapy for Central Versus Peripheral Lung Tumors
  Chaudhuri, A., Tang, C., Trakul, N., Wynne, J., Loo, B. W., & Diehn, M. (2014). Increased Rates of Pneumonitis in Patients Receiving Stereotactic Ablative Radiation Therapy for Central Versus Peripheral Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S160.
- Improving The Prognostic Value Of FDG-PET For NSCLC Patients Treated With SABR Using Advanced Computational Modeling
  Li, R., Aguilera, T. A., Shultz, D. B., Rubin, D., Diehn, M., & Loo, B. W. (2014). Improving The Prognostic Value Of FDG-PET For NSCLC Patients Treated With SABR Using Advanced Computational Modeling. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90, S7.
- CANCER STEM CELLS AND RADIORESISTANCE
  Diehn, M. (2011). CANCER STEM CELLS AND RADIORESISTANCE. JOURNAL OF THORACIC ONCOLOGY, 6(6), S166.
- The Effect of Arm Position on the Dosimetry of Thoracic Stereotactic Ablative Radiation Therapy
  Shultz, D. B., Tang, S. S., Diehn, M., Loo, B. W., & Maxim, P. (2013). The Effect of Arm Position on the Dosimetry of Thoracic Stereotactic Ablative Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), S736–S737.
- Clinical Implementation of Intrafraction CBCT Imaging During Lung Tumor SABR
  Li, R., Han, B., Meng, B., Maxim, P., Diehn, M., Xing, L., … Loo, B. (2013). Clinical Implementation of Intrafraction CBCT Imaging During Lung Tumor SABR. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), S726.
- Stromal Contributions to Radiation Resistance of Breast Cancer Stem Cells
  Bratman, S. V., VanderVorst, K., Feng, W., & Diehn, M. (2013). Stromal Contributions to Radiation Resistance of Breast Cancer Stem Cells. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), S633.
- Novel Imaging Biomarkers in Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy
  Aguilera, T. A., Daniel, G. I., Shultz, D. B., Trakul, N., Maxim, P. G., Rubin, D. L., … Diehn, M. (2013). Novel Imaging Biomarkers in Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), S546.
- Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema
  Binkley, M. S., Shrager, J. B., Trakul, N., Leung, A. N., Popat, R., Atwood, T. F., … Loo, B. W. (2013). Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), S545–S546.
- Prognostic Metrics on Serial PET for Lung Tumors Treated With Hypofractionated Radiation
  Harris, J. P., Chang-Halpenny, C. N., Maxim, P. G., Quon, A., Graves, E. E., Diehn, M., & Loo, B. W. (2013). Prognostic Metrics on Serial PET for Lung Tumors Treated With Hypofractionated Radiation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), S511.
- Analysis of Circulating Tumor Cells in Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy
  Wynne, J. F., Modlin, L. A., Fan, A., Tran, T., Schwartz, M., Loo, B. W., & Diehn, M. (2013). Analysis of Circulating Tumor Cells in Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), S200–S201.
- Validation of Image-Based Biomarkers for Analyzing Long-term Pulmonary Toxicity After Radiation Therapy
  King, M., Diehn, M., Loo, B., & Xing, L. (2013). Validation of Image-Based Biomarkers for Analyzing Long-term Pulmonary Toxicity After Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), S96.
- Performance of PET in Evaluating Local Recurrence After Stereotactic Ablative Radiation Therapy for Early Lung Cancer
  Hiniker, S. M., Modlin, L. A., Harris, J. P., Trakul, N., Quon, A., Maxim, P. G., … Loo, B. W. (2013). Performance of PET in Evaluating Local Recurrence After Stereotactic Ablative Radiation Therapy for Early Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(2), S11.
- Ray-trace Calculation Significantly Overestimates Dose Compared To Monte Carlo Calculation In CyberKnife Stereotactic Ablative Radiotherapy Of Lung Tumors
  Liu, M. B., Eclov, N., Trakul, N., Diehn, M., Maxim, P. G., Dieterich, S., & Loo, B. W. (2011). Ray-trace Calculation Significantly Overestimates Dose Compared To Monte Carlo Calculation In CyberKnife Stereotactic Ablative Radiotherapy Of Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(2), S853.
- Impact of Audiovisual Biofeedback on 4D-CT Image Quality
  Yamamoto, T., Gopalan, S., Cui, G., Diehn, M., Berger, J., Loo, B. W., & Keall, P. J. (2011). Impact of Audiovisual Biofeedback on 4D-CT Image Quality. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(2), S841–S842.
- Impact of Audiovisual Biofeedback on 4D PET Image Quality
  Yang, J., Yamamoto, T., Gopalan, S., Cui, G., Diehn, M., Berger, J., … Keall, P. J. (2011). Impact of Audiovisual Biofeedback on 4D PET Image Quality. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(2), S831–S832.
- RESPONSE TO "STEREOTACTIC ABLATIVE RADIOTHERAPY IN THE FRAMEWORK OF CLASSICAL RADIOBIOLOGY: RESPONSE TO DRS. BROWN, DIEHN, AND LOO." (INT J RADIAT ONCOL BIOL PHYS 2011;79:1599-1600) AND "INFLUENCE OF TUMOR HYPOXIA ON STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR): RESPONSE TO DRS. MAYER AND TIMMERMAN." (INT J RADIATION ONCOL BIOL PHYS 2011;78:1600) REPLY
  Brown, M., Loo, B. W., Diehn, M., & Carlson, D. J. (2011). RESPONSE TO "STEREOTACTIC ABLATIVE RADIOTHERAPY IN THE FRAMEWORK OF CLASSICAL RADIOBIOLOGY: RESPONSE TO DRS. BROWN, DIEHN, AND LOO." (INT J RADIAT ONCOL BIOL PHYS 2011;79:1599-1600) AND "INFLUENCE OF TUMOR HYPOXIA ON STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR): RESPONSE TO DRS. MAYER AND TIMMERMAN." (INT J RADIATION ONCOL BIOL PHYS 2011;78:1600) REPLY. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(4), 1194.
- Mechanisms of Radioresistance in Cancer Stem Cells
  Lee, C. Y.-F., & Diehn, M. (2011). Mechanisms of Radioresistance in Cancer Stem Cells. CANCER STEM CELLS IN SOLID TUMORS, 345–60.
- INFLUENCE OF TUMOR HYPOXIA ON STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR): RESPONSE TO DRS. MEYER AND TIMMERMAN
  Brown, M., Lao, B., Diehn, M., & Carlson, D. (2011). INFLUENCE OF TUMOR HYPOXIA ON STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR): RESPONSE TO DRS. MEYER AND TIMMERMAN. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 79(5), 1600.
- Circulating tumor DNA (ctDNA) in B-cell lymphoma
  Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2018). Circulating tumor DNA (ctDNA) in B-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY. WILEY.
- Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer.
  Harris, J. P., Nwachukwu, C., Qian, Y., Pollom, E., Loo, B. W., Das, M., & Diehn, M. (2018). Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands), 124, 76–85.
- Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non-Small-Cell Lung Cancer in the United States and Vietnam.
  Nguyen, K.-S. H., Stehr, H., Zhou, L., Nguyen, A.-H., Hiep, P. N., Van Cau, N., … Neal, J. W. (2018). Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non-Small-Cell Lung Cancer in the United States and Vietnam. Journal of Global Oncology, (4), 1–9.
- Analysis of Urinary Cell-free DNA for Early Detection and Surveillance of Bladder Cancer
  Dudley, J., Schroers-Martin, J., Lazzareschi, D., Shi, W., Chen, S., Liao, J., … Diehn, M. (2018). Analysis of Urinary Cell-free DNA for Early Detection and Surveillance of Bladder Cancer. JOURNAL OF MOLECULAR DIAGNOSTICS, 20(6), 968.
- The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
  Starkov, P., Aguilera, T. A., Golden, D. I., Shultz, D. B., Trakul, N., Maxim, P. G., … Rubin, D. L. (2018). The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy. The British Journal of Radiology, 20180228.
- Analysis of Circulating Tumor DNA Kinetics during Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung Cancer
  Chen, E. L., Chaudhuri, A. A., Nabet, B. Y., Chabon, J. J., Merriott, D. J., Loo, B. W., … Diehn, M. (2018). Analysis of Circulating Tumor DNA Kinetics during Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E676.
- F-18-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated with Highly Conformal Radiation Therapy
  Qian, Y., Von Eyben, R., Liu, Y., Chin, F., Miao, Z., Apte, S., … Loo, B. W. (2018). F-18-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated with Highly Conformal Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), S114–S115.
- Pulmonary Interstitial Lymphography and Patterns of Recurrence after Stereotactic Ablative Radiation Therapy(SABR) of Lung Tumors
  Ko, R. B., Abelson, J. A., Kothary, N., Fleischmann, D., Hofmann, L., Hovsepian, D., … Loo, B. W. (2018). Pulmonary Interstitial Lymphography and Patterns of Recurrence after Stereotactic Ablative Radiation Therapy(SABR) of Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E689.
- Predicting Per-Lesion Local Recurrence in Locally Advanced Lung Cancer using Metabolic Tumor Volume on Pre- and Mid-Radiation FDG-PET
  Binkley, M. S., Koenig, J. L., Sodji, Q., Maxim, P. G., Diehn, M., Loo, B. W., & Gensheimer, M. F. (2018). Predicting Per-Lesion Local Recurrence in Locally Advanced Lung Cancer using Metabolic Tumor Volume on Pre- and Mid-Radiation FDG-PET. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E674.
- Esophagitis in Patients Treated with Thoracic Stereotactic Ablative Radiation Therapy (SABR) to Tumors within 2 cm of the Esophagus
  Quaovi, S., Ko, R., Bush, K., Binkley, M. S., Pickthorn, W., Maxim, P. G., … Loo, B. W. (2018). Esophagitis in Patients Treated with Thoracic Stereotactic Ablative Radiation Therapy (SABR) to Tumors within 2 cm of the Esophagus. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E666.
- Radiologic Quantification and Predictors of Lung Fibrosis after Stereotactic Ablative Radiation Therapy(SABR)
  Ross, J. B., Schueler, E., Ko, R., Bush, K., Maxim, P. G., Gensheimer, M. F., … Diehn, M. (2018). Radiologic Quantification and Predictors of Lung Fibrosis after Stereotactic Ablative Radiation Therapy(SABR). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(3), E703.
- Genomic Profiling of Bronchoalveolar Lavage Fluid in Patients with Non-Small Cell Lung Cancer
  Nair, V. S., Li, A. B.-H., Stehr, H., Chabon, J., Chaudhuri, A., Zhou, L., … Diehn, M. (2018). Genomic Profiling of Bronchoalveolar Lavage Fluid in Patients with Non-Small Cell Lung Cancer. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197.
- Deep Sequencing Reveals High Allelic Frequencies of Tumor Mutations in the High Risk Airway Epithelium
  Atwater, T., Rahman, S., Diehn, M., & Massion, P. P. (2018). Deep Sequencing Reveals High Allelic Frequencies of Tumor Mutations in the High Risk Airway Epithelium. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197.
- Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer
  Blumenthal, G. M., Bunn, P. A., Chaft, J. E., McCoach, C. E., Perez, E. A., Scagliotti, G. V., … Kris, M. G. (2018). Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 13(12), 1818–31.
- Detection and surveillance of bladder cancer using urine tumor DNA.
  Dudley, J. C., Schroers-Martin, J., Lazzareschi, D. V., Shi, W. Y., Chen, S. B., Esfahani, M. S., … Diehn, M. (2018). Detection and surveillance of bladder cancer using urine tumor DNA. Cancer Discovery.
- Noninvasive detection of clinically relevant copy number alterations in diffuse large B-cell lymphoma.
  Jin, M. C., Kurtz, D. M., Esfahani, M. S., Scherer, F., Craig, A. F. M., Soo, J., … Alizadeh, A. A. (2017). Noninvasive detection of clinically relevant copy number alterations in diffuse large B-cell lymphoma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Reply to J. Wang et al.
  Kurtz, D. M., Scherer, F., Jin, M. C., Soo, J., Craig, A. F., Esfahani, M. S., … Alizadeh, A. A. (2019). Reply to J. Wang et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO1801907.
- Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib.
  Wang, S. X., Zhang, B. M., Wakelee, H. A., Koontz, M. Z., Pan, M. G., Diehn, M., … Neal, J. W. (2019). Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib. Anti-Cancer Drugs.
- Sinoatrial node dysfunction after stereotactic ablative radiation therapy in the chest
  Qian, Y., Dudley, S. A., Kumar, K., Chaudhuri, A., Chin, A., Harris, J. P., … Loo, B. W. (2017). Sinoatrial node dysfunction after stereotactic ablative radiation therapy in the chest. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing
  Schroers-Martin, J. G., Garofalo, A., Soo, J., Jin, M. C., Kurtz, D. M., Buedts, L., … Alizadeh, A. A. (2018). Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing. BLOOD, 132.
- Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma
  Jin, M. C., Schroers-Martin, J. G., Kurtz, D. M., Buedts, L., Esfahani, M. S., Macaulay, C., … Alizadeh, A. A. (2018). Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma. BLOOD, 132.
- Distinct Chromatin Accessibility Profiles of Lymphoma Subtypes Revealed By Targeted Cell Free DNA Profiling
  Mehrmohamadi, M., Esfahani, M. S., Soo, J., Scherer, F., Schroers-Martin, J. G., Chen, B., … Alizadeh, A. A. (2018). Distinct Chromatin Accessibility Profiles of Lymphoma Subtypes Revealed By Targeted Cell Free DNA Profiling. BLOOD, 132.
- Elucidation of distinct mutational patterns between diffuse large B cell lymphoma subtypes utilizing circulating tumor DNA.
  Soo, J., Kurtz, D. M., Scherer, F., Craig, A. F. M., Jin, M. C., Westin, J. R., … Alizadeh, A. A. (2017). Elucidation of distinct mutational patterns between diffuse large B cell lymphoma subtypes utilizing circulating tumor DNA. JOURNAL OF CLINICAL ONCOLOGY, 35.
- Genetic approaches using primary megakaryocytes to identify effectors of platelet integrin signaling
  Shattil, S. J., Bertoni, A., Eto, K., Murphy, R., Pampori, N., Shiraga, M., … Leavitt, A. D. (2001). Genetic approaches using primary megakaryocytes to identify effectors of platelet integrin signaling. MOLECULAR BIOLOGY OF THE CELL, 12, 270A.
- DNA microarrays as "microscopes" for watching a genome in action
  Brown, P. O., Botstein, D., Alizadeh, A., Derisi, J., Diehn, M., Eisen, M., … Staudt, L. (1998). DNA microarrays as "microscopes" for watching a genome in action. MOLECULAR BIOLOGY OF THE CELL, 9, 2A.
- Caspase-12 expression is markedly reduced in NF-E2(-/-)megakaryocytes and caspase-12(-/-) platelets exhibit a defect in integrin alpha IIb beta 3 inside-out signaling.
  Kerrigan, S. W., Murphy, R. P., Alizadeh, A., Diehn, M., Shattil, S. J., & Leavitt, A. D. (2002). Caspase-12 expression is markedly reduced in NF-E2(-/-)megakaryocytes and caspase-12(-/-) platelets exhibit a defect in integrin alpha IIb beta 3 inside-out signaling. BLOOD, 100(11), 13A.
- SABR-COMET: harbinger of a new cancer treatment paradigm.
  Loo, B. W., & Diehn, M. (2019). SABR-COMET: harbinger of a new cancer treatment paradigm. Lancet (London, England).
- A phase II randomized trial of observation versus stereotactic ablative radiation for oligometastatic prostate cancer (ORIOLE).
  Phillips, R., Radwan, N., Ross, A., Rowe, S. P., Gorin, M. A., Antonarakis, E. S., … Tran, P. T. (2017). A phase II randomized trial of observation versus stereotactic ablative radiation for oligometastatic prostate cancer (ORIOLE). JOURNAL OF CLINICAL ONCOLOGY, 35.
- Increases in Serial Pretreatment 18F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy.
  Prionas, N. D., von Eyben, R., Yi, E., Aggarwal, S., Shaffer, J., Bazan, J., … Loo, B. W. (2019). Increases in Serial Pretreatment 18F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy. Advances in Radiation Oncology, 4(2), 429–37.
- Genomic Feature Selection by Coverage Design Optimization.
  Reid, S., Newman, A. M., Diehn, M., Alizadeh, A. A., & Tibshirani, R. (2018). Genomic Feature Selection by Coverage Design Optimization. Journal of Applied Statistics, 45(14), 2658–2676.
- Feasibility and potential utility of multicomponent exhaled breath analysis for predicting development of radiation pneumonitis after stereotactic ablative radiotherapy.
  Moré, J. M., Eclov, N. C., Chung, M. P., Wynne, J. F., Shorter, J. H., Nelson, D. D., … Diehn, M. (2014). Feasibility and potential utility of multicomponent exhaled breath analysis for predicting development of radiation pneumonitis after stereotactic ablative radiotherapy. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 9(7), 957–64.
- Prognostic Value of Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma Reply
  Kurtz, D. M., Scherer, F., Jin, M. C., Soo, J., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2019). Prognostic Value of Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma Reply. JOURNAL OF CLINICAL ONCOLOGY, 37(9), 755-+.
- Clinical and Pathological Variables Influencing Noninvasive Detection of Early Stage Lung Cancer Using Circulating Tumor DNA
  Chabon, J., Chaudhuri, A., Azad, T., Kurtz, D., Stehr, H., Liu, C. L., … Diehn, M. (2017). Clinical and Pathological Variables Influencing Noninvasive Detection of Early Stage Lung Cancer Using Circulating Tumor DNA. JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC.
- Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
  Dudley, J. C., Schroers-Martin, J., Lazzareschi, D., Shi, W., Chen, S. B., Esfahani, M. S., … Diehn, M. (2019). Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA. CANCER DISCOVERY, 9(4), 500–509.
- Determining cell type abundance and expression from bulk tissues with digital cytometry.
  Newman, A. M., Steen, C. B., Liu, C. L., Gentles, A. J., Chaudhuri, A. A., Scherer, F., … Alizadeh, A. A. (2019). Determining cell type abundance and expression from bulk tissues with digital cytometry. Nature Biotechnology.
- GFPT2-Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma
  Zhang, W., Bouchard, G., Yu, A., Shafiq, M., Jamali, M., Shrager, J. B., … Plevritis, S. K. (2018). GFPT2-Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma. CANCER RESEARCH, 78(13), 3445–57.
- Combination Approach for Detecting Different Types of Alterations in Circulating Tumor DNA in Leiomyosarcoma
  Przybyl, J., Chabon, J. J., Spans, L., Ganjoo, K. N., Vennam, S., Newman, A. M., … van de Rijn, M. (2018). Combination Approach for Detecting Different Types of Alterations in Circulating Tumor DNA in Leiomyosarcoma. CLINICAL CANCER RESEARCH, 24(11), 2688–99.
- Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
  Kurtz, D. M., Scherer, F., Jin, M. C., Soo, J., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2018). Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 36(28), 2845-+.
- Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib
  Wang, S. X. Y., Zhang, B. M., Wakelee, H. A., Koontz, M. Z., Pan, M. G., Diehn, M., … Neal, J. W. (2019). Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib. ANTI-CANCER DRUGS, 30(5), 537–41.
- Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer
  Harris, J. P., Nwachukwu, C., Qian, Y., Pollom, E., Loo, B. W., Das, M., & Diehn, M. (2018). Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer. LUNG CANCER, 124, 76–85.
- SABR-COMET: harbinger of a new cancer treatment paradigm
  Loo, B. W., & Diehn, M. (2019). SABR-COMET: harbinger of a new cancer treatment paradigm. LANCET, 393(10185), 2013–14.
- The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
  Starkov, P., Aguilera, T. A., Golden, D., Shultz, D. B., Trakul, N., Maxim, P. G., … Rubin, D. L. (2019). The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy. BRITISH JOURNAL OF RADIOLOGY, 92(1094).
- A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer
  Lee, J., Li, B., Cui, Y., Sun, X., Wu, J., Zhu, H., … Li, R. (2018). A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(4), 1098–1106.
- F-18-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy
  Qian, Y., Von Eyben, R., Liu, Y., Chin, F. T., Miao, Z., Apte, S., … Loo Jr, B. W. (2018). F-18-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102(4), 1183–92.
- Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer
  Chin, A. L., Kumar, K. A., Guo, H. H., Maxim, P. G., Wakelee, H., Neal, J. W., … Gensheimer, M. F. (2018). Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer. CLINICAL LUNG CANCER, 19(5), E581–E588.
- Line-Enhanced Deformable Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy With Radiation-Induced Fibrosis
  King, M., Sensakovic, W. F., Maxim, P., Diehn, M., Loo, B. W., & Xing, L. (2018). Line-Enhanced Deformable Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy With Radiation-Induced Fibrosis. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 17.
- A Feasibility Study of Single-inhalation, Single-energy Xenon-enhanced CT for High-resolution Imaging of Regional Lung Ventilation in Humans
  Pinkham, D. W., Negandar, M., Yamamoto, T., Mittra, E., Diehn, M., Nair, V. S., … Loo, B. W. (2019). A Feasibility Study of Single-inhalation, Single-energy Xenon-enhanced CT for High-resolution Imaging of Regional Lung Ventilation in Humans. ACADEMIC RADIOLOGY, 26(1), 38–49.
- Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors
  Liu, M. B., Eclov, N. C. W., Trakul, N., Murphy, J., Diehn, M., Le, Q.-T., … Loo, B. W. (2013). Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors. PRACTICAL RADIATION ONCOLOGY, 3(4), 294–300.
- Circulating tumor DNA analysis for outcome prediction in localized esophageal cancer.
  Azad, T. D., Chaudhuri, A., Newman, A. M., Stehr, H., Schroers-Martin, J., Chabon, J. J., … Diehn, M. (2017). Circulating tumor DNA analysis for outcome prediction in localized esophageal cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Quantitating circulating tumor DNA in translocation-positive sarcoma patients using CAPP-Seq
  Shah, A. T., Azad, T. D., Chabon, J. J., Breese, M., Tanasa, B., Spillinger, A., … Sweet-Cordero, E. A. (2018). Quantitating circulating tumor DNA in translocation-positive sarcoma patients using CAPP-Seq. CANCER RESEARCH, 78(19).
- FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study
  Hiniker, S. M., Sodji, Q., Quon, A., Gutkin, P. M., Arksey, N., Graves, E. E., … Loo, B. W. (2019). FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study. FRONTIERS IN ONCOLOGY, 9.
- Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non-Small-Cell Lung Cancer in the United States and Vietnam
  Nguyen, K.-S. H., Stehr, H., Zhou, L., Anh-Hoa Nguyen, Pham Nhu Hiep, Nguyen Van Cau, … Neal, J. W. (2018). Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non-Small-Cell Lung Cancer in the United States and Vietnam. JOURNAL OF GLOBAL ONCOLOGY, 4.
- Circulating tumor DNA testing in advanced non-small cell lung cancer
  Moding, E. J., Diehn, M., & Wakelee, H. A. (2018). Circulating tumor DNA testing in advanced non-small cell lung cancer. LUNG CANCER, 119, 42–47.
- FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study.
  Hiniker, S. M., Sodji, Q., Quon, A., Gutkin, P. M., Arksey, N., Graves, E. E., … Loo, B. W. (2019). FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study. Frontiers in Oncology, 9, 467.
- Early detection of post-transplant lymphoproliferative disorder using circulating tumor DNA.
  Soo, J., Schroers-Martin, J., Garofalo, A., Kurtz, D. M., D'Emilio, N., & Grimm, D. R. (2018). Early detection of post-transplant lymphoproliferative disorder using circulating tumor DNA. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Post-transplant head and neck cancers: A prospective analysis of clinical factors for risk stratification.
  Soo, J., Schroers-Martin, J., Garofalo, A., Kurtz, D. M., D'Emilio, N., & Grimm, D. R. (2018). Post-transplant head and neck cancers: A prospective analysis of clinical factors for risk stratification. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Noninvasive molecular subtyping and risk stratification of DLBCL.
  Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2016). Noninvasive molecular subtyping and risk stratification of DLBCL. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.
  Kurtz, D. M., Esfahani, M. S., Scherer, F., Soo, J., Jin, M. C., Liu, C. L., … Alizadeh, A. A. (2019). Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction. Cell.
- Inter- and intra-patient heterogeneity of resistance mechanisms to the mutant EGFR selective inhibitor rociletinib.
  Chabon, J. ., Simmons, A., Newman, A. M., Lovejoy, A. F., Esfahani, M. S., Haringsma, H., … Diehn, M. (2016). Inter- and intra-patient heterogeneity of resistance mechanisms to the mutant EGFR selective inhibitor rociletinib. JOURNAL OF CLINICAL ONCOLOGY, 34(15).
- Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer.
  Hellyer, J. A., Stehr, H., Das, M., Padda, S. K., Ramchandran, K., Neal, J. W., … Wakelee, H. A. (2019). Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands), 134, 42–45.
- Molecular Profiling of Oligometastases and Artificial Intelligence-based Model for Predicting Treatment Outcome in Advance Prostate Cancer
  Heidari, N., Bagshaw, H. P., Diehn, M., Snyder, M., & Buyyounouski, M. K. (2019). Molecular Profiling of Oligometastases and Artificial Intelligence-based Model for Predicting Treatment Outcome in Advance Prostate Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 104(5), 1195.
- Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors.
  Moding, E. J., Liang, R., Lartey, F. M., Maxim, P. G., Sung, A., Diehn, M., … Gensheimer, M. F. (2019). Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors. Clinical Lung Cancer.
- Determining cell type abundance and expression from bulk tissues with digital cytometry
  Newman, A. M., Steen, C. B., Liu, C. L., Gentles, A. J., Chaudhuri, A. A., Scherer, F., … Alizadeh, A. A. (2019). Determining cell type abundance and expression from bulk tissues with digital cytometry. NATURE BIOTECHNOLOGY, 37(7), 773-+.
- Integrated digital error suppression for noninvasive detection of circulating tumor DNA in NSCLC.
  Newman, A. M., Lovejoy, A. F., Klass, D. M., Kurtz, D. M., Chabon, J. J., Scherer, F., … Diehn, M. (2016). Integrated digital error suppression for noninvasive detection of circulating tumor DNA in NSCLC. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Randomized phase II study of preoperative chemoradiotherapy (CRT) plus /-Panitumumab (P) followed by consolidation chemotherapy (C) in potentially operable locally advanced (stage Ma, N2+) non -small cell lung cancer (LANSCLC): Nrg oncology/RTOG 0839.
  Edelman, M. J., Hu, C., Le, Q.-T., Donington, J., D'Souza, W. D., Dicker, A., … Bradley, J. D. (2016). Randomized phase II study of preoperative chemoradiotherapy (CRT) plus /-Panitumumab (P) followed by consolidation chemotherapy (C) in potentially operable locally advanced (stage Ma, N2+) non -small cell lung cancer (LANSCLC): Nrg oncology/RTOG 0839. JOURNAL OF CLINICAL ONCOLOGY, 34(15).
- Role of KEAP1/NFE2L2 mutations in the chemotherapeutic response of non-small cell lung cancer patients.
  Jeong, Y., Hellyer, J. A., Stehr, H., Hoang, N. T., Niu, X., Das, M., … Diehn, M. (2019). Role of KEAP1/NFE2L2 mutations in the chemotherapeutic response of non-small cell lung cancer patients. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Circulating Tumor DNA Changes During Chemoradiation for Lung Cancer Predict Patient Outcomes
  Moding, E. J., Nabet, B. Y., Liu, Y., Chabon, J. J., Chaudhuri, A. A., Hui, A. B., … Diehn, M. (2019). Circulating Tumor DNA Changes During Chemoradiation for Lung Cancer Predict Patient Outcomes. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), S113.
- Investigating and Validating Metabolic Tumor Volume As a Prognostic Factor for Local Recurrence in Early Stage Lung Cancer
  Binkley, M. S., Stehr, H., Moding, E. J., Owen, S. G., Ko, R., Maxim, P. G., … Diehn, M. (2019). Investigating and Validating Metabolic Tumor Volume As a Prognostic Factor for Local Recurrence in Early Stage Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E497.
- Influence of Dose and Fractionation on Radiologic Lung Fibrosis after Stereotactic Ablative Radiotherapy (SABR)
  Ross, J. B., Ross, J. B., Merriott, D. J., Alhumaid, S., Schueler, E., Ko, R. B., … Diehn, M. (2019). Influence of Dose and Fractionation on Radiologic Lung Fibrosis after Stereotactic Ablative Radiotherapy (SABR). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E527–E528.
- Symptomatic Cardiac Events in Patients with Lung Tumors Near The Heart Treated with Stereotactic Ablative Radiotherapy (SABR): A Single Institution Experience
  Ko, R. B., Jani, K., Sodji, Q., Merriott, D. J., Pickthorn, W., Bush, K., … Loo, B. W. (2019). Symptomatic Cardiac Events in Patients with Lung Tumors Near The Heart Treated with Stereotactic Ablative Radiotherapy (SABR): A Single Institution Experience. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), S148.
- Outcomes of Oligometastatic Colorectal Cancer treated with Stereotactic Ablative Radiotherapy
  Benson, K., Sandhu, N., Zhang, C., Ko, R. B., Toesca, D. A. S., Von Eyben, R., … Chang, D. T. (2019). Outcomes of Oligometastatic Colorectal Cancer treated with Stereotactic Ablative Radiotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), E161–E162.
- Primary Outcomes of a Phase II Randomized Trial of Observation Versus Stereotactic Ablative RadiatIon for OLigometastatic Prostate CancEr (ORIOLE)
  Phillips, R., Lim, S. J., Shi, W. Y., Antonarakis, E. S., Rowe, S., Gorin, M., … Tran, P. T. (2019). Primary Outcomes of a Phase II Randomized Trial of Observation Versus Stereotactic Ablative RadiatIon for OLigometastatic Prostate CancEr (ORIOLE). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(3), 681.
- ctDNA analysis for personalization of consolidation immunotherapy in localized non-small cell lung cancer.
  Moding, E. J., Liu, Y., Nabet, B., Chabon, J. J., Chaudhuri, A., Hui, A. B., … Diehn, M. (2019). ctDNA analysis for personalization of consolidation immunotherapy in localized non-small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY, 37(15).
- Predicting HLA class II antigen presentation through integrated deep learning.
  Chen, B., Khodadoust, M. S., Olsson, N., Wagar, L. E., Fast, E., Liu, C. L., … Alizadeh, A. A. (2019). Predicting HLA class II antigen presentation through integrated deep learning. Nature Biotechnology.
- Broad Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer
  Nair, V., Hui, A. B.-Y., Chabon, J., Esfahani, M., Stehr, H., Nabet, B., … Diehn, M. (2019). Broad Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 14(10), S747–S748.
- Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer.
  Azad, T. D., Chaudhuri, A. A., Fang, P., Qiao, Y., Esfahani, M. S., Chabon, J. J., … Diehn, M. (2019). Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer. Gastroenterology.
- Deep segmentation networks predict survival of non-small cell lung cancer.
  Baek, S., He, Y., Allen, B. G., Buatti, J. M., Smith, B. J., Tong, L., … Wu, X. (2019). Deep segmentation networks predict survival of non-small cell lung cancer. Scientific Reports, 9(1), 17286.
- Atlas of clinically-distinct cell states and cellular ecosystems across human solid tumors
  Luca, B., Alizadeh, A., Diehn, M., Newman, A., Gentles, A., & Steen, C. (2019). Atlas of clinically-distinct cell states and cellular ecosystems across human solid tumors. JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC.
- Functional significance of U2AF1 S34F mutations in lung adenocarcinomas.
  Esfahani, M. S., Lee, L. J., Jeon, Y.-J. J., Flynn, R. A., Stehr, H., Hui, A. B., … Diehn, M. (2019). Functional significance of U2AF1 S34F mutations in lung adenocarcinomas. Nature Communications, 10(1), 5712.
- Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma
  Alig, S., Macaulay, C., Kurtz, D. M., Ulrich, D., Andreas, H., Jin, M. C., … Alizadeh, A. A. (2019). Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma. Blood.
- Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA
  Kurtz, D. M., Soo, J., Alig, S., Keh, L. C. T., Macaulay, C., Jin, M. C., … Alizadeh, A. A. (2019). Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA. Blood.
- Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling
  Esfahani, M. S., Alig, S., Kurtz, D. M., Soo, J., Jin, M. C., Macaulay, C., … Alizadeh, A. A. (2019). Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling. Blood.
- Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy
  Sworder, B., Kurtz, D. M., Macaulay, C., Frank, M. J., Alig, S., Garofalo, A., … Alizadeh, A. A. (2019). Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy. Blood.
- Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL
  Macaulay, C., Alig, S., Kurtz, D. M., Jin, M. C., Opat, S., Soo, J., … Alizadeh, A. A. (2019). Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL. Blood.
- Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC.
  Hellmann, M. D., Nabet, B. Y., Rizvi, H., Chaudhuri, A. A., Wells, D. K., Dunphy, M. P., … Diehn, M. (2020). Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Characterizing metastatic cancer stem cells from human breast cancer
  Liu, H., Qian, D., Lin, J., Lobo, N., Zhang, H., Dalerba, P., … Clarke, M. (2008). Characterizing metastatic cancer stem cells from human breast cancer. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Increases in Serial Pretreatment F-18-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy
  Prionas, N. D., von Eyben, R., Yi, E., Aggarwal, S., Shaffer, J., Bazan, J., … Loo, B. W. (2019). Increases in Serial Pretreatment F-18-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy. ADVANCES IN RADIATION ONCOLOGY, 4(2), 429–37.
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.
  Phillips, R., Shi, W. Y., Deek, M., Radwan, N., Lim, S. J., Antonarakis, E. S., … Tran, P. T. (2020). Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. JAMA Oncology.
- Integrating genomic features for non-invasive early lung cancer detection
  Chabon, J. J., Hamilton, E. G., Kurtz, D. M., Esfahani, M. S., Moding, E. J., Stehr, H., … Diehn, M. (2020). Integrating genomic features for non-invasive early lung cancer detection. NATURE.
- Integrating genomic features for non-invasive early lung cancer detection.
  Chabon, J. J., Hamilton, E. G., Kurtz, D. M., Esfahani, M. S., Moding, E. J., Stehr, H., … Diehn, M. (2020). Integrating genomic features for non-invasive early lung cancer detection. Nature, 580(7802), 245–251.
- A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk.
  Gentles, A. J., Hui, A. B.-Y., Feng, W., Azizi, A., Nair, R. V., Bouchard, G., … Plevritis, S. K. (2020). A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk. Genome Biology, 21(1), 107.
- Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
  Moding, E. J., Liu, Y., Nabet, B. Y., Chabon, J. J., Chaudhuri, A. A., Hui, A. B., … Diehn, M. (2020). Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer. NATURE CANCER, 1.
- Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable.
  Kirsch, D. G., Diehn, M., Cucinoata, F. A., & Weichselbaum, R. (2020). Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology.
- Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume.
  Binkley, M. S., Koenig, J. L., Kashyap, M., Xiang, M., Liu, Y., Sodji, Q., … Gensheimer, M. F. (2020). Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume. Radiation Oncology (London, England), 15(1), 114.
- A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
  Tran, P. T., Phillips, R., Shi, W., Lim, S. J., Antonarakis, E. S., Rowe, S. P., … Diehn, M. (2020). A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE). JOURNAL OF CLINICAL ONCOLOGY, 38(6).
- Functional significance of U2AF1 S34F mutations in lung adenocarcinomas
  Shahrokh Esfahani, M. (2019). Functional significance of U2AF1 S34F mutations in lung adenocarcinomas. Nature Communications, 10.
- Response Letter: Radiation therapy for COVID-19 pneumopathy.
  Kirsch, D. G., Diehn, M., Cucinotta, F. A., & Weichselbaum, R. (2020). Response Letter: Radiation therapy for COVID-19 pneumopathy. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology.
- An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma
  Steen, C. B., Luca, B. A., Esfahani, M. S., Nabet, B. Y., Sworder, B., Farshidfar, F., … Alizadeh, A. A. (2019). An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma. BLOOD, 134.
- Deep Sequencing of Viral Cell-Free DNA for Noninvasive Detection of Immunosuppression-Related Lymphoid Malignancies
  Garofalo, A., Schroers-Martin, J. G., Soo, J., Kurtz, D. M., Sworder, B., Liu, C. L., … Alizadeh, A. A. (2019). Deep Sequencing of Viral Cell-Free DNA for Noninvasive Detection of Immunosuppression-Related Lymphoid Malignancies. BLOOD. AMER SOC HEMATOLOGY.
- ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.
  Dasari, A., Morris, V. K., Allegra, C. J., Atreya, C., Benson, A. B., Boland, P., … Kopetz, S. (2020). ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper. Nature Reviews. Clinical Oncology.
- Molecular and immunological signatures are related to clinical benefit from treatment with Vocimagene amiretrorepvec (Toca 511) and 5-fluorocytosine (Toca FC) in patients with glioma.
  Accomando, W. P., Rao, A. R., Hogan, D. J., Newman, A. M., Nakao, A., Alizadeh, A. A., … Ostertag, D. (2020). Molecular and immunological signatures are related to clinical benefit from treatment with Vocimagene amiretrorepvec (Toca 511) and 5-fluorocytosine (Toca FC) in patients with glioma. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
  Nabet, B. Y., Esfahani, M. S., Moding, E. J., Hamilton, E. G., Chabon, J. J., Rizvi, H., … Diehn, M. (2020). Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition. Cell.
- Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.
  Zhang, N., Liang, R., Gensheimer, M. F., Guo, M., Zhu, H., Yu, J., … Wu, J. (2020). Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer. Theranostics, 10(25), 11707–18.
- KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition.
  Binkley, M. S., Jeon, Y.-J. J., Nesselbush, M., Moding, E. J., Nabet, B. Y., Almanza, D., … Diehn, M. (2020). KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition. Cancer Discovery.
- Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
  Moding, E. J., Liu, Y., Nabet, B. Y., Chabon, J. J., Chaudhuri, A. A., Hui, A. B., … Diehn, M. (2020). Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer. Nature Cancer, 1.
- Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA.
  Dudley, J. C., & Diehn, M. (2020). Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA. Annual Review of Pathology.
- Cardiac Toxicities and Outcomes Following Stereotactic Ablative Radiation to Thoracic Cancers
  Obeid, J. P., Natarajan, J. M., Ko, R., Jani, K., Sodji, Q., Merriott, D. J., … Loo, B. W. (2020). Cardiac Toxicities and Outcomes Following Stereotactic Ablative Radiation to Thoracic Cancers. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(3), E158–E159.
- Parametric Response Mapping as an Imaging Biomarker for Regional Ventilation in Stereotactic Ablative Radiotherapy
  Capaldi, D. P., Binkley, M. S., Ko, R., Xing, L., Maxim, P. G., Diehn, M., & Loo, B. W. (2020). Parametric Response Mapping as an Imaging Biomarker for Regional Ventilation in Stereotactic Ablative Radiotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(3), E359.
- Pre-Treatment Lung FDG-PET Uptake is Correlated with Radiologic Lung Fibrosis after Stereotactic Ablative Radiotherapy (SABR)
  Ross, J. B., Merriott, D. J., Alhumaid, S., Schueler, E., Ko, R., Bush, K., … Diehn, M. (2020). Pre-Treatment Lung FDG-PET Uptake is Correlated with Radiologic Lung Fibrosis after Stereotactic Ablative Radiotherapy (SABR). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(3), E155.
- American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.
  Pennell, N. A., Dillmon, M., Levit, L. A., Moushey, E. A., Alva, A. S., Blau, S., … Burris, H. A. (2020). American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2002953.
- Clinical implications of KEAP1-NFE2L2 mutations in non-small cell lung cancer.
  Hellyer, J. A., Padda, S. K., Diehn, M., & Wakelee, H. A. (2020). Clinical implications of KEAP1-NFE2L2 mutations in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer.
- A mathematical model of ctDNA shedding predicts tumor detection size.
  Avanzini, S., Kurtz, D. M., Chabon, J. J., Moding, E. J., Hori, S. S., Gambhir, S. S., … Reiter, J. G. (2020). A mathematical model of ctDNA shedding predicts tumor detection size. Science Advances, 6(50).
- Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy.
  Wisdom, A. J., Mowery, Y. M., Hong, C. S., Himes, J. E., Nabet, B. Y., Qin, X., … Kirsch, D. G. (2020). Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy. Nature Communications, 11(1), 6410.
- Targeted Treatment of Multiple Primary Lung Cancers Harboring Distinct EGFR or RET Alterations: A Case Report.
  Aredo, J. V., Diehn, M., Berry, G. J., & Wakelee, H. A. (2020). Targeted Treatment of Multiple Primary Lung Cancers Harboring Distinct EGFR or RET Alterations: A Case Report. Clinical Lung Cancer.
- Durvalumab for Patients with Stage III EGFR-Mutated Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy
  Aredo, J. V., Hellyer, J. A., Neal, J. W., Padda, S. K., McCoach, C. E., Riess, J. W., … Wakelee, H. A. (2021). Durvalumab for Patients with Stage III EGFR-Mutated Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy. JOURNAL OF THORACIC ONCOLOGY, 16(1), S15.
- Durvalumab for Stage III EGFR-Mutated Non-Small Cell Lung Cancer After Definitive Chemoradiotherapy.
  Aredo, J. V., Mambetsariev, I., Hellyer, J. A., Amini, A., Neal, J. W., Padda, S. K., … Wakelee, H. A. (2021). Durvalumab for Stage III EGFR-Mutated Non-Small Cell Lung Cancer After Definitive Chemoradiotherapy. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer.
- A review of immunotherapy for stage 3 and metastatic NSCLC & the rationale for the ECOG-ACRIN EA5181 study.
  Varlotto, J. M., Sun, Z., Ky, B., Upshaw, J., Katz, S. I., Fitzgerald, T. J., … Pennell, N. A. (2021). A review of immunotherapy for stage 3 and metastatic NSCLC & the rationale for the ECOG-ACRIN EA5181 study. The Oncologist.
- Atlas of clinically-distinct cell states and cellular ecosystems across human solid tumors
  Luca, B. A., Steen, C. B., Azizi, A., Matusiak, M., Przybyl, J., Neishaboori, N., … Newman, A. M. (2020). Atlas of clinically-distinct cell states and cellular ecosystems across human solid tumors. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer
  Nabet, B. Y., Esfahani, M. S., Hamilton, E. G., Chabon, J. J., Moding, E. J., Rizvi, H., … Diehn, M. (2020). A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Chromatin accessibility patterns in cell-free DNA reveal tumor heterogeneity
  Esfahani, M. S., Mehrmohamadi, M., Steen, C. B., Hamilton, E. G., King, D. A., Soo, J., … Alizadeh, A. A. (2020). Chromatin accessibility patterns in cell-free DNA reveal tumor heterogeneity. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Analytical validation of iSort digital cytometry for leukocyte enumeration in clinical tumor specimens.
  Newman, A. M., Nakao, A., Li, K., Wilson, D. C., Liu, C.-L., Diehn, M., & Alizadeh, A. A. (2020). Analytical validation of iSort digital cytometry for leukocyte enumeration in clinical tumor specimens. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.
  Chiou, S.-H. H., Tseng, D., Reuben, A., Mallajosyula, V., Molina, I. S., Conley, S., … Davis, M. M. (2021). Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity, 54(3), 586–602.e8.
- Genetic determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo.
  Foggetti, G., Li, C., Cai, H., Hellyer, J. A., Lin, W.-Y., Ayeni, D., … Politi, K. (2021). Genetic determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo. Cancer Discovery.
- Stereotactic Ablative Radiotherapy for Central and Ultra-Central Lung Tumors.
  Chaudhuri, A. A., Chen, K., Diehn, M., & Loo, B. W. (2019). Stereotactic Ablative Radiotherapy for Central and Ultra-Central Lung Tumors. Therapeutic Radiology and Oncology, 3.
- Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma.
  Alig, S., Macaulay, C. W., Kurtz, D. M., Dührsen, U., Hüttmann, A., Schmitz, C., … Alizadeh, A. A. (2021). Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2002573.
- Relationship between KEAP1/NFE2L2 pathway activation and radiation resistance in oral cavity cancer.
  Guan, L., Cao, H., Hui, A., Kwok, S., Viswanathan, V., Nambiar, D., … Quynh-Thu Le. (2021). Relationship between KEAP1/NFE2L2 pathway activation and radiation resistance in oral cavity cancer. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer.
  Binkley, M. S., Jeon, Y.-J., Nesselbush, M., Moding, E. J., Nabet, B., Almanza, D., … Diehn, M. (2021). Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Circulating tumor DNA kinetics to identify genomic predictors of rapid response to chemoradiation in non-small cell lung cancer.
  Moding, E. J., Liu, Y., Hui, A. B., He, J., Qiao, Y., Xu, T., … Diehn, M. (2021). Circulating tumor DNA kinetics to identify genomic predictors of rapid response to chemoradiation in non-small cell lung cancer. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Analyzing the sensitivity of breast cancer stem cells to ionizing radiation and chemotherapy
  Diehn, M., Cho, R., Dorie, M., Kulp, A., Weissman, I. L., Brown, M., & Clarke, M. F. (2007). Analyzing the sensitivity of breast cancer stem cells to ionizing radiation and chemotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 69(3), S38–S39.
- Genome-scale identification of secreted and membrane-associated tumor markers
  Diehn, M., Bhattacharya, R., Botstein, D., & Brown, P. O. (2005). Genome-scale identification of secreted and membrane-associated tumor markers. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 63(2), S458.
- Investigating differential gene expression in anatomical compartments of the human eye using cDNA microarrays
  Diehn, J. J., Diehn, M., Marmor, M. F., & Brown, P. O. (2004). Investigating differential gene expression in anatomical compartments of the human eye using cDNA microarrays. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 45, U324.
- Correlative MR imaging with GBM cancer genomics
  Kuo, M., Nardini, C., Cha, S., & Diehn, M. (2005). Correlative MR imaging with GBM cancer genomics. NEURO-ONCOLOGY, 7(3), 399.
- MRI-guided insights into differential gene expression patterns in GBMs based on tumor location
  Kuo, M. D., Nardini, C., Wang, D. S., Cha, S., & Diehn, M. (2005). MRI-guided insights into differential gene expression patterns in GBMs based on tumor location. AMERICAN JOURNAL OF ROENTGENOLOGY, 184(4), 5.
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
  Merker, J. D., Oxnard, G. R., Compton, C., Diehn, M., Hurley, P., Lazar, A. J., … Turner, N. C. (2018). Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. JOURNAL OF CLINICAL ONCOLOGY, 36(16), 1631-+.
- Circulating Tumor DNA Analysis in Patients With Cancer American Society of Clinical Oncology and College of American Pathologists Joint Review
  Merker, J. D., Oxnard, G. R., Compton, C., Diehn, M., Hurley, P., Lazar, A. J., … Turner, N. C. (2018). Circulating Tumor DNA Analysis in Patients With Cancer American Society of Clinical Oncology and College of American Pathologists Joint Review. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 142(10), 1242–1253.
- Gene expression profiles of primary cutaneous T cell lymphoma with focus on CD 30+ anaplastic large cell lymphoma (ALCL): unique clustering pattern of ALCL with extensive limb presentation
  Storz, M. N., Kim, Y. H., van de Rijn, M., Dick, S., Hoppe, R. T., Diehn, M., & Kohler, S. (2004). Gene expression profiles of primary cutaneous T cell lymphoma with focus on CD 30+ anaplastic large cell lymphoma (ALCL): unique clustering pattern of ALCL with extensive limb presentation. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 122(3), A20.
- Functional genomic analysis of CD4+CD25+ regulatory T cells.
  Seeley, E., Ermann, J., Diehn, M., & Fathman, C. G. (2002). Functional genomic analysis of CD4+CD25+ regulatory T cells. CLINICAL IMMUNOLOGY, 103(3), S68.
- Higher-grade transformed follicle center lymphomas (FCL): Gene expression profiling comparison to pre-transformed FCL and to de novo diffuse large B-cell lymphomas (DLBCL).
  Lossos, I. S., Alizadeh, A. A., Diehn, M., Warnke, R., Brown, P. O., Botstein, D., & Levy, R. (2001). Higher-grade transformed follicle center lymphomas (FCL): Gene expression profiling comparison to pre-transformed FCL and to de novo diffuse large B-cell lymphomas (DLBCL). BLOOD. AMER SOC HEMATOLOGY.
- Liquid Biopsy for Advanced Non-Small Cell Lung Cancer: A Consensus Statement from The International Association for the Study of Lung Cancer (IASLC).
  Rolfo, C., Mack, P., Scagliotti, G. V., Aggarwal, C., Arcila, M. E., Barlesi, F., … Gandara, D. (2021). Liquid Biopsy for Advanced Non-Small Cell Lung Cancer: A Consensus Statement from The International Association for the Study of Lung Cancer (IASLC). Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer.
- Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA.
  Kurtz, D. M., Soo, J., Co Ting Keh, L., Alig, S., Chabon, J. J., Sworder, B. J., … Alizadeh, A. A. (2021). Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. Nature Biotechnology.
- A comprehensive circulating tumor DNA assay for detection of translocation and copy number changes in pediatric sarcomas.
  Shah, A. T., Azad, T. D., Breese, M. R., Chabon, J. J., Hamilton, E. G., Straessler, K., … Sweet-Cordero, E. A. (2021). A comprehensive circulating tumor DNA assay for detection of translocation and copy number changes in pediatric sarcomas. Molecular Cancer Therapeutics.
- Radiological tumour classification across imaging modality and histology
  Wu, J., Li, C., Gensheimer, M., Padda, S., Kato, F., Shirato, H., … Li, R. (2021). Radiological tumour classification across imaging modality and histology. NATURE MACHINE INTELLIGENCE.
- Mutational landscape of the bronchial epithelium of individuals at high risk for lung cancer.
  Rahman, S. M. J., Zhao, S., Chu, S.-K., Zou, Y., Hui, A. B., Stricker, T. P., … Massion, P. P. (2021). Mutational landscape of the bronchial epithelium of individuals at high risk for lung cancer. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.
  Moding, E. J., Liu, Y., Nabet, B. Y., Chabon, J. J., Chaudhuri, A. A., Hui, A. B., … Diehn, M. (2020). Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer. Nature Cancer, 1(2), 176–183.
- Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy.
  Benson, K. R., Sandhu, N., Zhang, C., Ko, R., Toesca, D. A., Lee, P. E., … Chang, D. T. (2021). Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy. American Journal of Clinical Oncology.
- Atlas of clinically distinct cell states and ecosystems across human solid tumors.
  Luca, B. A., Steen, C. B., Matusiak, M., Azizi, A., Varma, S., Zhu, C., … Newman, A. M. (2021). Atlas of clinically distinct cell states and ecosystems across human solid tumors. Cell.
- The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.
  Steen, C. B., Luca, B. A., Esfahani, M. S., Azizi, A., Sworder, B. J., Nabet, B. Y., … Alizadeh, A. A. (2021). The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell.
- Pulmonary Hemorrhage in Patients Treated with Thoracic Stereotactic Ablative Radiotherapy and Anti-Angiogenic Agents
  Lau, B., No, H., (Fred) Wu, Y., Devine, M., Ko, R., Loo, B., … Vitzthum, L. (2021). Pulmonary Hemorrhage in Patients Treated with Thoracic Stereotactic Ablative Radiotherapy and Anti-Angiogenic Agents. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
- Treatment Patterns for Isolated Nodal Recurrences in Non-Small Cell Lung Cancer After Definitive Stereotactic Ablative Radiotherapy
  No, H., Devine, M., Lau, B., Loo, B., Diehn, M., Chin, A., & Vitzthum, L. (2021). Treatment Patterns for Isolated Nodal Recurrences in Non-Small Cell Lung Cancer After Definitive Stereotactic Ablative Radiotherapy. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
- Deep Learning Based Identification and Segmentation of Lung Tumors on Computed Tomography Images.
  Kashyap, M., Panjwani, N., Hasan, M. A., Huang, C., Bush, K., Dong, P., … Gensheimer, M. F. (2021). Deep Learning Based Identification and Segmentation of Lung Tumors on Computed Tomography Images. International Journal of Radiation Oncology, Biology, Physics, 111(3S), e92–e93.
- Patterns of Care in Patients With Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer.
  Devine, M., Merriott, D. J., Say, C., Yoo, C., Yi, E., Lau, B., … Vitzthum, L. (2021). Patterns of Care in Patients With Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics, 111(3S), e435.
- A Phase II Trial of Individualized Stereotactic Ablative Radiotherapy for Lung Tumors (iSABR).
  Gensheimer, M. F., Gee, H. E., Von Eyben, R., Shirato, H., Taguchi, H., Wong, S., … Diehn, M. (2021). A Phase II Trial of Individualized Stereotactic Ablative Radiotherapy for Lung Tumors (iSABR). International Journal of Radiation Oncology, Biology, Physics, 111(3S), S89–S90.
- Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC).
  Marar, M., Bryant, A. K., Nalawade, V., Das, M., Jr, B. W., Diehn, M., … Vitzthum, L. (2021). Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology, Biology, Physics, 111(3S), e447.
- Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease.
  Moding, E. J., Nabet, B. Y., Alizadeh, A. A., & Diehn, M. (2021). Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease. Cancer Discovery.
- Phased variants improve DLBCL minimal residual disease detection at the end of therapy.
  Kurtz, D. M., Chabon, J. J., Soo, J., Keh, L. C. T., Alig, S., Schultz, A., … Alizadeh, A. A. (2021). Phased variants improve DLBCL minimal residual disease detection at the end of therapy. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Noninvasive identification of emergent mutations following cytotoxic therapy for lung cancer.
  Moding, E. J., Hui, A. B., Murciano-Goroff, Y. R., Nabet, B., Schultz, A., Qiao, Y., … Diehn, M. (2021). Noninvasive identification of emergent mutations following cytotoxic therapy for lung cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Pulmonary Hemorrhage in Patients Treated With Thoracic Stereotactic Ablative Radiotherapy and Anti-Angiogenic Agents
  Lau, B., No, H. J., Wu, Y. F., Ko, R. B., Devine, M., Das, M., … Vitzthum, L. (2021). Pulmonary Hemorrhage in Patients Treated With Thoracic Stereotactic Ablative Radiotherapy and Anti-Angiogenic Agents. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Patterns of Care in Patients With Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer
  Devine, M., Merriott, D. J., Say, C., Yoo, C., Yi, E., Lau, B., … Vitzthum, L. (2021). Patterns of Care in Patients With Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- A Phase II Trial of Individualized Stereotactic Ablative Radiotherapy for Lung Tumors (iSABR)
  Gensheimer, M. F., Gee, H. E., Von Eyben, R., Shirato, H., Taguchi, H., Wong, S., … Diehn, M. (2021). A Phase II Trial of Individualized Stereotactic Ablative Radiotherapy for Lung Tumors (iSABR). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Deep Learning Based Identification and Segmentation of Lung Tumors on Computed Tomography Images
  Kashyap, M., Panjwani, N., Hasan, M. A. S. A., Huang, C., Bush, K., Dong, P., … Gensheimer, M. F. (2021). Deep Learning Based Identification and Segmentation of Lung Tumors on Computed Tomography Images. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
  Marar, M., Bryant, A. K., Nalawade, V., Das, M., Loo, B. W., Diehn, M., … Vitzthum, L. (2021). Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Radiological tumor classification across imaging modality and histology.
  Wu, J., Li, C., Gensheimer, M., Padda, S., Kato, F., Shirato, H., … Li, R. (2021). Radiological tumor classification across imaging modality and histology. Nature Machine Intelligence, 3, 787–798.
- Acute and Late Esophageal Toxicity Following Stereotactic Ablative Radiotherapy to Thoracic Tumors near or Abutting the Esophagus.
  Sodji, Q. H., Ko, R., von Eyben, R., Owen, S. G., Capaldi, D. P., Bush, K., … Loo, B. W. (1800). Acute and Late Esophageal Toxicity Following Stereotactic Ablative Radiotherapy to Thoracic Tumors near or Abutting the Esophagus. International Journal of Radiation Oncology, Biology, Physics.
- Predictive Radiation Oncology - A New NCI-DOE Scientific Space and Community.
  Buchsbaum, J. C., Jaffray, D. A., Ba, D., Borkon, L. L., Chalk, C., Chung, C., … Willcox, K. E. (1800). Predictive Radiation Oncology - A New NCI-DOE Scientific Space and Community. Radiation Research.
- Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT.
  Sodji, Q. H., Harris, J. P., Quon, A., Modlin, L. A., Lau, B., Jiang, A., … Hiniker, S. M. (2022). Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT. Clinical Lung Cancer.
- Circulating tumor DNA profiling for noninvasive detection, classification, and risk stratification of patients with CNS lymphomas
  Mutter, J. A., Alig, S., Lauer, E. M., Esfahani, M. S., Mitschke, J., Kurtz, D. M., … Scherer, F. (2021). Circulating tumor DNA profiling for noninvasive detection, classification, and risk stratification of patients with CNS lymphomas. ONCOLOGY RESEARCH AND TREATMENT. KARGER.
- Inferring gene expression from cell-free DNA fragmentation profiles.
  Esfahani, M. S., Hamilton, E. G., Mehrmohamadi, M., Nabet, B. Y., Alig, S. K., King, D. A., … Alizadeh, A. A. (2022). Inferring gene expression from cell-free DNA fragmentation profiles. Nature Biotechnology.
- Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA.
  Yaung, S. J., Woestmann, C., Ju, C., Ma, X. M., Gattam, S., Zhou, Y., … Muley, T. (2022). Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA. Cancers, 14(10).
- Characterization of Metastatic Non-Small Cell Lung Cancer and Oligometastatic Incidence in an Era of Changing Treatment Paradigms.
  No, H. J., Raja, N., Von Eyben, R., Das, M., Roy, M., Myall, N., … Vitzthum, L. K. (2022). Characterization of Metastatic Non-Small Cell Lung Cancer and Oligometastatic Incidence in an Era of Changing Treatment Paradigms. International Journal of Radiation Oncology, Biology, Physics.
- Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.
  Nair, V. S., Hui, A. B., Chabon, J. J., Shahrokh Esfahani, M., Stehr, H., Nabet, B. Y., … Diehn, M. (2022). Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer. Cancer Research.
- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group.
  Pascual, J., Attard, G., Bidard, F.-C., Curigliano, G., De Mattos-Arruda, L., Diehn, M., … Turner, N. C. (2022). ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. Annals of Oncology : Official Journal of the European Society for Medical Oncology.
- Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer.
  Devine, M., Merriott, D. J., No, H. J., Lau, B., Say, C., Yoo, C., … Vitzthum, L. K. (2022). Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer. Practical Radiation Oncology.
- Noninvasive Cell-of-Origin Classification of Diffuse Large B-Cell Lymphoma Using Inferred Gene Expression from Cell-Free DNA Sequencing
  Esfahani, M. S., Alig, S., Mehrmohamadi, M., Hamilton, E. G., King, D. A., Schultz, A., … Alizadeh, A. A. (2021). Noninvasive Cell-of-Origin Classification of Diffuse Large B-Cell Lymphoma Using Inferred Gene Expression from Cell-Free DNA Sequencing. BLOOD. AMER SOC HEMATOLOGY.
- Early Outcomes and Toxicity with Concurrent Chemotherapy and Hypofractionated Radiation Therapy in Patients with Non-Small Cell Lung Cancer
  Hui, C., Marquez, C., Lau, B., Von Eyben, R., Das, M., Myall, N., … Vitzthum, L. (2022). Early Outcomes and Toxicity with Concurrent Chemotherapy and Hypofractionated Radiation Therapy in Patients with Non-Small Cell Lung Cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
- Dosimetric Predictors of Local Control after Stereotactic Ablative Radiotherapy (SABR) for Lung Tumors: A Secondary Analysis of a Phase II Prospective Trial of Individualized SABR (iSABR)
  Wu, Y. F., Lau, B., Fu, J., Skinner, L., Gensheimer, M., Gee, H., … Vitzthum, L. (2022). Dosimetric Predictors of Local Control after Stereotactic Ablative Radiotherapy (SABR) for Lung Tumors: A Secondary Analysis of a Phase II Prospective Trial of Individualized SABR (iSABR). AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
- Chest Wall Toxicity after Individualized Stereotactic Ablative Radiotherapy for Lung Tumors
  Lau, B., Wu, Y. F., Fu, J., Cui, S., Pham, D., Gee, H., … Vitzthum, L. (2022). Chest Wall Toxicity after Individualized Stereotactic Ablative Radiotherapy for Lung Tumors. JOURNAL OF THORACIC ONCOLOGY. ELSEVIER SCIENCE INC.
- Analysis of circulating tumor DNA in the phase 2 BTCRC LUN 16-081 trial of consolidation nivolumab with or without ipilimumab after chemoradiation in stage III non-small cell lung cancer.
  Jun, S., Shukla, N., Durm, G. A., Hui, A. B., Cao, S., Kunder, C., … Diehn, M. (2022). Analysis of circulating tumor DNA in the phase 2 BTCRC LUN 16-081 trial of consolidation nivolumab with or without ipilimumab after chemoradiation in stage III non-small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect.
  Nishiga, Y., Drainas, A. P., Baron, M., Bhattacharya, D., Barkal, A. A., Ahrari, Y., … Sage, J. (2022). Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect. Nature Cancer.
- A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181.
  Varlotto, J. M., Sun, Z., Ky, B., Upshaw, J., Fitzgerald, T. J., Diehn, M., … Pennell, N. A. (2022). A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181. Clinical Lung Cancer, 23(7), 547–560.
- Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer.
  Aredo, J. V., Wakelee, H. A., Hui, A. B.-Y., Padda, S. K., Joshi, N. D., Guo, H. H., … Neal, J. W. (2022). Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer. Cancer Treatment and Research Communications, 33, 100659.
- Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade.
  Spurr, L. F., Martinez, C. A., Kang, W., Chen, M., Zha, Y., Hseu, R., … Pitroda, S. P. (2022). Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade. Nature Cancer.
- Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.
  Mutter, J. A., Alig, S. K., Esfahani, M. S., Lauer, E. M., Mitschke, J., Kurtz, D. M., … Scherer, F. (2022). Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2200826.
- Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
  Sworder, B. J., Kurtz, D. M., Alig, S. K., Frank, M. J., Shukla, N., Garofalo, A., … Alizadeh, A. A. (2022). Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas. Cancer Cell.
- STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.
  Katipally, R. R., Spurr, L. F., Gutiontov, S. I., Turchan, W. T., Connell, P., Juloori, A., … Pitroda, S. P. (2023). STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer. JCO Precision Oncology, 7, e2200273.
- NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells.
  Guan, L., Nambiar, D. K., Cao, H., Viswanathan, V., Kwok, S., Hui, A. B., … Le, Q.-T. T. (2023). NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells. Cancer Research.
- Viral cfDNA Profiling Reveals Distinct EBV Subtypes and Stratifies Risk in Hodgkin Lymphomas
  Garofalo, A., Alig, S. K., Schroers-Martin, J., Shyam, R. M., Olsen, M., Kurtz, D. M., … Alizadeh, A. A. (2022). Viral cfDNA Profiling Reveals Distinct EBV Subtypes and Stratifies Risk in Hodgkin Lymphomas. BLOOD. AMER SOC HEMATOLOGY.
- Distinct Molecular Subtypes of Classic Hodgkin Lymphoma Identified By Comprehensive Noninvasive Profiling
  Alig, S. K., Esfahani, M. S., Li, M. Y., Adams, R. M., Garofalo, A., Jin, M. C., … Alizadeh, A. A. (2022). Distinct Molecular Subtypes of Classic Hodgkin Lymphoma Identified By Comprehensive Noninvasive Profiling. BLOOD. AMER SOC HEMATOLOGY.
- Tumor Microenvironment Determinants of Immunotherapy Response Identified By Integrated Host & Viral Analysis of Post-Transplant Lymphoproliferative Disorders
  Schroers-Martin, J., Garofalo, A., Soo, J., Boegeholz, J., Alig, S. K., Sworder, B., … Alizadeh, A. A. (2022). Tumor Microenvironment Determinants of Immunotherapy Response Identified By Integrated Host & Viral Analysis of Post-Transplant Lymphoproliferative Disorders. BLOOD. AMER SOC HEMATOLOGY.
- Specificity & Precision of Minimal Residual Disease Monitoring in DLBCL Using Ig-HTS
  Shukla, N. D., Schroers-Martin, J., Kathuria, K. R., Sworder, B., Alig, S. K., Frank, M. J., … Alizadeh, A. A. (2022). Specificity & Precision of Minimal Residual Disease Monitoring in DLBCL Using Ig-HTS. BLOOD. AMER SOC HEMATOLOGY.
- Determinants of Resistance to Engineered T-Cell Therapies Targeting CD19 in Large B-Cell Lymphomas
  Sworder, B., Kurtz, D. M., Alig, S. K., Frank, M. J., Shukla, N. D., Garofalo, A., … Alizadeh, A. A. (2022). Determinants of Resistance to Engineered T-Cell Therapies Targeting CD19 in Large B-Cell Lymphomas. BLOOD. AMER SOC HEMATOLOGY.
- Ultrasensitive MRD Profiling Predicts Outcomes in DLBCL after Frontline Therapy with Tafasitamab in Combination with Lenalidomide and R-CHOP
  Kurtz, D. M., Hogan, G. J., Schultz, A., Kopeckova, K., Kuffer, C., Blair, D., … Westin, J. (2022). Ultrasensitive MRD Profiling Predicts Outcomes in DLBCL after Frontline Therapy with Tafasitamab in Combination with Lenalidomide and R-CHOP. BLOOD. AMER SOC HEMATOLOGY.
- MRD-Negativity As a Potential Surrogate Endpoint after Frontline DLBCL Therapy: Pooled Analysis of Trials & Implications for Clinical Trial Design
  Roschewski, M., Kurtz, D. M., Westin, J., Lynch, R. C., Macaulay, C., Kuffer, C., … Schultz, A. (2022). MRD-Negativity As a Potential Surrogate Endpoint after Frontline DLBCL Therapy: Pooled Analysis of Trials & Implications for Clinical Trial Design. BLOOD. AMER SOC HEMATOLOGY.
- Investigating the Impact of Coronary Artery Dosimetry on Major Adverse Cardiac Events after Thoracic Radiation Therapy
  Guo, F. B., No, H. J., Rhee, J. W., Chin, A. L., Vitzthum, L., Horst, K. C., … Binkley, M. S. (2022). Investigating the Impact of Coronary Artery Dosimetry on Major Adverse Cardiac Events after Thoracic Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Characterizing Metastatic Non-Small Cell Lung Cancer Presenting to an Academic Medical Center in an Era of Changing Treatment Paradigms
  Raja, N., No, H. J., Von Eyben, R., Das, M., Roy, M., Myall, N., … Vitzthum, L. (2022). Characterizing Metastatic Non-Small Cell Lung Cancer Presenting to an Academic Medical Center in an Era of Changing Treatment Paradigms. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Higher Rates of Severe Infection and Persistent Cytopenias in Long-Term CAR19 Responders Than after Autologous HCT: A Single Institution Study of 139 Subjects
  Hamilton, M. P., Liu-Fei, F. C., Alig, S. K., Tamaresis, J., Esfahani, M. S., Good, Z., … Alizadeh, A. A. (2022). Higher Rates of Severe Infection and Persistent Cytopenias in Long-Term CAR19 Responders Than after Autologous HCT: A Single Institution Study of 139 Subjects. BLOOD. AMER SOC HEMATOLOGY.
- Clonal Hematopoiesis Driven By Recurrent Somatic Mutations but Not with Recurrent Copy Number Alterations Is Associated with Inferior Outcomes in DLBCL after Induction Chemotherapy, but Not CAR19 Therapy
  Boegeholz, J., Alig, S. K., Sworder, B., Schroers-Martin, J., Macaulay, C., Craig, A. F. M., … Alizadeh, A. A. (2022). Clonal Hematopoiesis Driven By Recurrent Somatic Mutations but Not with Recurrent Copy Number Alterations Is Associated with Inferior Outcomes in DLBCL after Induction Chemotherapy, but Not CAR19 Therapy. BLOOD. AMER SOC HEMATOLOGY.
- Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors.
  Schroers-Martin, J. G., Soo, J., Brisou, G., Scherer, F., Kurtz, D. M., Sworder, B. J., … Alizadeh, A. A. (2023). Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors. Cancer Discovery.
- Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging.
  Alhusaini, S., Lanman, T. A., Ko, R. B., Therkelsen, K. E., Eyben, R. V., Diehn, M., … Nagpal, S. (2023). Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging. Frontiers in Oncology, 13, 1139940.
- Pulmonary Hemorrhage in Patients Treated with Thoracic Stereotactic Ablative Radiotherapy and Anti-Angiogenic Agents.
  Lau, B., Wu, Y. F., No, H. J., Ko, R. B., Devine, M., Das, M. S., … Vitzthum, L. K. (2023). Pulmonary Hemorrhage in Patients Treated with Thoracic Stereotactic Ablative Radiotherapy and Anti-Angiogenic Agents. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer.
- Unilateral diaphragmatic paralysis after stereotactic ablative radiotherapy to a lung tumor abutting the course of the phrenic nerve.
  Eke, I., Guo, H. H., Loo, J. B., Sung, A. W., Diehn, M., Vitzthum, L., … Gensheimer, M. F. (2023). Unilateral diaphragmatic paralysis after stereotactic ablative radiotherapy to a lung tumor abutting the course of the phrenic nerve. Practical Radiation Oncology.
- Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal.
  Bestvina, C. M., Garassino, M. C., Neal, J. W., Wakelee, H. A., Diehn, M., & Vokes, E. E. (2023). Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2300258.
- Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled Trial.
  Gensheimer, M. F., Gee, H., Shirato, H., Taguchi, H., Snyder, J. M., Chin, A. L., … Diehn, M. (2023). Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled Trial. JAMA Oncology.
- Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.
  Lauer, E. M., Riegler, E., Mutter, J. A., Alig, S. K., Bleul, S., Kuehn, J., … Scherer, F. (2023). Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas. Neuro-Oncology.
- Association between locoregional failure and NFE2L2/KEAP1/CUL3 pathway mutations in NRG/RTOG 9512: A randomized trial of hyperfractionation vs. conventional fractionation in T2N0 glottic squamous cell carcinoma (SCC).
  Guan, L., Torres-Saavedra, P. A., Zhao, X., Major, M. B., Holmes, B. J., Nguyen, N., … Hayes, D. N. (2023). Association between locoregional failure and NFE2L2/KEAP1/CUL3 pathway mutations in NRG/RTOG 9512: A randomized trial of hyperfractionation vs. conventional fractionation in T2N0 glottic squamous cell carcinoma (SCC). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Investigating Dosimetry and Imaging Biomarkers for Prediction of Major Adverse Cardiac Events Following Locally Advanced Non-Small Cell Lung Cancer Radiotherapy.
  No, H. J., Park, N. J., Guo, F. B., Kastelowitz, N., Snyder, J. M., Rhee, J. W., … Binkley, M. S. (2023). Investigating Dosimetry and Imaging Biomarkers for Prediction of Major Adverse Cardiac Events Following Locally Advanced Non-Small Cell Lung Cancer Radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 117(2S), S170.
- Predicting Local Control with Dosimetric Parameters in Patients Receiving Individualized Stereotactic Ablative Radiotherapy for Lung Tumors.
  Wu, Y. F., Lau, B., Fu, J., Cui, S., Pham, D., Dubrowski, P., … Vitzthum, L. (2023). Predicting Local Control with Dosimetric Parameters in Patients Receiving Individualized Stereotactic Ablative Radiotherapy for Lung Tumors. International Journal of Radiation Oncology, Biology, Physics, 117(2S), e76.
- Hyperfractionated Reirradiation for Locally Recurrent Thoracic Tumors.
  Butler, S. S., Raclin, T., Lau, B., Raja, N., Chin, A. L., Skinner, L., … Vitzthum, L. (2023). Hyperfractionated Reirradiation for Locally Recurrent Thoracic Tumors. International Journal of Radiation Oncology, Biology, Physics, 117(2S), e9.
- Concurrent Radiation and Immunotherapy Augments Local Immunity and Improves Survival in Aneuploid NSCLC.
  Spurr, L. F., Martinez, C., Kang, W., Chen, M., Zha, Y., Hseu, R., … Pitroda, S. P. (2023). Concurrent Radiation and Immunotherapy Augments Local Immunity and Improves Survival in Aneuploid NSCLC. International Journal of Radiation Oncology, Biology, Physics, 117(2S), S23.
- Prospective Trial of Using Imaging to Predict Pathologic Response and Clinical Outcomes in Locally Advanced Esophageal Cancer.
  Liu, Y., Hobbs, B. P., Hofstetter, W., Murphy, M. B., Gandhi, S., Nguyen, Q. N., … Lin, S. H. (2023). Prospective Trial of Using Imaging to Predict Pathologic Response and Clinical Outcomes in Locally Advanced Esophageal Cancer. International Journal of Radiation Oncology, Biology, Physics, 117(2S), S12–S13.
- Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial.
  Hui, C., Brown, E., Wong, S., Das, M., Wakelee, H., Neal, J., … Vitzthum, L. K. (2023). Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial. Clinical Lung Cancer.
- Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non-Small-Cell Lung Cancer.
  Hui, C., Marquez, C., Lau, B., Das, M., Myall, N. J., Roy, M., … Vitzthum, L. K. (2023). Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non-Small-Cell Lung Cancer. Clinical Lung Cancer.
- Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.
  Alig, S. K., Esfahani, M. S., Garofalo, A., Li, M. Y., Rossi, C., Flerlage, T., … Alizadeh, A. A. (2023). Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Nature.
- Specificity of Immunoglobulin High-Throughput Sequencing Minimal Residual Disease Monitoring in Non-Hodgkin Lymphomas.
  Shukla, N., Schroers-Martin, J., Sworder, B., Kathuria, K. R., Alig, S., Frank, M. J., … Alizadeh, A. A. (2023). Specificity of Immunoglobulin High-Throughput Sequencing Minimal Residual Disease Monitoring in Non-Hodgkin Lymphomas. Blood Advances.
- Pulmonary interstitial lymphography: A prospective trial with potential impact on stereotactic ablative radiotherapy planning for early-stage lung cancer.
  Ko, R. B., Abelson, J. A., Fleischmann, D., Louie, J. D., Hwang, G. L., Sze, D. Y., … Loo, B. W. (2023). Pulmonary interstitial lymphography: A prospective trial with potential impact on stereotactic ablative radiotherapy planning for early-stage lung cancer. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 110079.
- Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer.
  No, H. J., Guo, F. B., Park, N. J.-I., Kastelowitz, N., Rhee, J.-W. W., Clark, D. E., … Binkley, M. S. (2023). Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer. JACC. CardioOncology, 5(6), 775–787.
- A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment.
  Kastenschmidt, J. M., Schroers-Martin, J. G., Sworder, B. J., Sureshchandra, S., Khodadoust, M. S., Liu, C. L., … Alizadeh, A. A. (2024). A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment. Cell Stem Cell.
- CAR19 Therapy Drives Expansion of Clonal Hematopoiesis and Associated Cytopenias
  Hamilton, M. P., Sworder, B. J., Alig, S. K., Good, Z., Boegeholz, J., Schroers-Martin, J., … Alizadeh, A. A. (2023). CAR19 Therapy Drives Expansion of Clonal Hematopoiesis and Associated Cytopenias. BLOOD. AMER SOC HEMATOLOGY.
- Genomic, Transcriptional, and Immunological Validation of Distinct Molecular Subtypes of Classic Hodgkin Lymphoma through Tissue-Based and Noninvasive Methods
  Alig, S. K., Esfahani, M. S., Garofalo, A., Li, M. Y., Rossi, C., Flerlage, T., … Alizadeh, A. A. (2023). Genomic, Transcriptional, and Immunological Validation of Distinct Molecular Subtypes of Classic Hodgkin Lymphoma through Tissue-Based and Noninvasive Methods. BLOOD. AMER SOC HEMATOLOGY.
- Phased Variants Allow Robust Profiling of Circulating Tumor DNA in Untreated Follicular Lymphomas
  Nagy, A., Batai, B., Hogan, G., Chabon, J. J., Troke, M., Riley, L., … Bodor, C. (2023). Phased Variants Allow Robust Profiling of Circulating Tumor DNA in Untreated Follicular Lymphomas. BLOOD. AMER SOC HEMATOLOGY.
- An Integrated Multimodal Framework for Noninvasive TCL Disease Detection and Monitoring
  Sugio, T., Shukla, N., Khodadoust, M. S., Nesselbush, M., Kato, K., Alig, S. K., … Alizadeh, A. A. (2023). An Integrated Multimodal Framework for Noninvasive TCL Disease Detection and Monitoring. BLOOD. AMER SOC HEMATOLOGY.
- End-of-Treatment Response Assessment after Frontline Therapy for Aggressive B-Cell Lymphoma: Landmark Comparison of a Singular PET/CT Scan Versus Ultrasensitive Circulating Tumor DNA
  Roschewski, M., Lindenberg, L., Mena, E., Lakhotia, R., Melani, C., Steinberg, S. M., … Wilson, W. H. (2023). End-of-Treatment Response Assessment after Frontline Therapy for Aggressive B-Cell Lymphoma: Landmark Comparison of a Singular PET/CT Scan Versus Ultrasensitive Circulating Tumor DNA. BLOOD. AMER SOC HEMATOLOGY.
- Inferred Gene Expression By Cell-Free DNA Profiling Allows Noninvasive Lymphoma Classification
  Mutter, J. A., Esfahani, M. S., Schroers-Martin, J., Alig, S. K., Hamilton, M. P., Sworder, B. J., … Alizadeh, A. A. (2023). Inferred Gene Expression By Cell-Free DNA Profiling Allows Noninvasive Lymphoma Classification. BLOOD. AMER SOC HEMATOLOGY.
- Prognostic Utility of Minimal Residual Disease (MRD) after Curative Intent Induction Therapy for DLBCL: A Prospective Real-World Ctdna Study
  Sworder, B. J., Yoon, S. E., Kim, S. J., Schultz, A., Hogan, G., Close, S., … Kim, W. S. (2023). Prognostic Utility of Minimal Residual Disease (MRD) after Curative Intent Induction Therapy for DLBCL: A Prospective Real-World Ctdna Study. BLOOD. AMER SOC HEMATOLOGY.
- Optimizing Circulating Tumor DNA Limits of Detection for DLBCL during First Line Therapy
  Goldstein, J., Kim, W. S., Yoon, S. E., Kim, S. J., Roschewski, M., Westin, J., … Kurtz, D. M. (2023). Optimizing Circulating Tumor DNA Limits of Detection for DLBCL during First Line Therapy. BLOOD. AMER SOC HEMATOLOGY.
- Longitudinal Noninvasive Surveillance & Fragmentomic Characterization of Follicular Lymphoma
  Schroers-Martin, J., Mutter, J. A., Esfahani, M. S., Scherer, F., Soo, J., Alig, S. K., … Alizadeh, A. A. (2023). Longitudinal Noninvasive Surveillance & Fragmentomic Characterization of Follicular Lymphoma. BLOOD. AMER SOC HEMATOLOGY.
- Distinct Circulating Genomic Features of Classical Hodgkin Lymphoma of Older Adults
  Rossi, C., Boegeholz, J., Alig, S. K., Garofalo, A., Esfahani, M. S., Schroers-Martin, J., … Alizadeh, A. A. (2023). Distinct Circulating Genomic Features of Classical Hodgkin Lymphoma of Older Adults. BLOOD. AMER SOC HEMATOLOGY.
- Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
  Passaro, A., Al Bakir, M., Hamilton, E. G., Diehn, M., André, F., Roy-Chowdhuri, S., … Peters, S. (2024). Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. Cell, 187(7), 1617–1635.
- First in human Phase I Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema.
  Kamtam, D. N., Binkley, M. S., Kapula, N., Sadeghi, C., Nesbit, S., Md, H. H., … Shrager, J. B. (2024). First in human Phase I Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema. International Journal of Radiation Oncology, Biology, Physics.
- Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trial.
  Lau, B., Wu, Y. F., Cui, S., Fu, J., Jackson, S., Pham, D., … Vitzthum, L. K. (2024). Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trial. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 110317.
- Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis.
  Azad, T. D., Nanjo, S., Jin, M. C., Chabon, J. J., Kurtz, D. M., Chaudhuri, A. A., … Diehn, M. (2024). Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis. NPJ Precision Oncology, 8(1), 121.
- Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.
  Hamilton, M. P., Sugio, T., Noordenbos, T., Shi, S., Bulterys, P. L., Liu, C. L., … Miklos, D. B. (2024). Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. The New England Journal of Medicine, 390(22), 2047–2060.
- Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients.
  Mathew, D., Marmarelis, M. E., Foley, C., Bauml, J. M., Ye, D., Ghinnagow, R., … Minn, A. J. (2024). Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Science (New York, N.Y.), 384(6702), eadf1329.
- Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer.
  Lee, N. Y., Morris, L. G., & Diehn, M. (2024). Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer. JAMA Oncology.
- Analysis of Circulating Tumor DNA Predicts Outcomes of Short Course Consolidation Immunotherapy in Unresectable Stage III Non-Small Cell Lung Cancer.
  Jun, S., Shukla, N. A., Durm, G., Hui, A. B., Cao, S., Ganti, A. K., … Diehn, M. (2024). Analysis of Circulating Tumor DNA Predicts Outcomes of Short Course Consolidation Immunotherapy in Unresectable Stage III Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer.
- 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
  Alig, S. K., Esfahani, M. S., Garofalo, A., Li, M. Y., Rossi, C., Adams, R., … Alizadeh, A. A. (2023). 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023. Hematological Oncology, 41 Suppl 2, 96–98.
- 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
  Rossi, C., Boegeholz, J. L., Alig, S. K., Garofolo, A., Esfahani, M. S., Schroers-Martin, J., … Alizadeh, A. A. (2023). 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023. Hematological Oncology, 41 Suppl 2, 321–322.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer

Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Molecular and Cellular Analysis of Breast Cancer

Molecular Analysis of Thoracic Malignancies

Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer

Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer

Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study

CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

Specializing In

Radiation oncology
Radiation Therapy

Practice Locations

Radiation Oncology at Blake Wilbur Building Palo Alto, CA

Palo Alto, CA

Radiation Oncology at Blake Wilbur Building

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur Palo Alto, CA

Palo Alto, CA

CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Thoracic Cancer Program in Palo Alto Palo Alto, CA

Palo Alto, CA

Thoracic Cancer Program in Palo Alto

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(10 Ratings)

Overall Rating

5.0/5

View Ratings by Category

5.0/5

Friendliness

5.0/5

Explanations

5.0/5

Listens

5.0/5

Care provider's efforts to include you in decisions about your care

5.0/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(46 reviews)

Excellent and caring provider

Oct 2024

•

Verified SHC Patient

He's the best!

Sep 2024

•

Verified SHC Patient

Very easy to talk to. Puts me at ease. Very caring and thourgh! Iâ€™m so grateful to have had him as my doctor and I appreciate the success of my treatment!!!

Nov 2023

•

Verified SHC Patient

Excellent Doctor

Oct 2023

•

Verified SHC Patient

The wonderful thing about the team is I really feel they care, and they are very focused. Also this time the visit went like clockwork.

Aug 2023

•

Verified SHC Patient

Doctor explained in details and followed up with question and answer session. I was very happy with all the answers to my questions

Feb 2023

•

Verified SHC Patient

The best!

Jan 2023

•

Verified SHC Patient

He was very helpful and caring about clarifying what was needed to be done.

Sep 2022

•

Verified SHC Patient

I am very pleased with Dr. Diehn. He is very focused , extremely intelligent and concerned about your well being. I feel very fortunate being one of his patients.

Jul 2022

•

Verified SHC Patient

Excellent knowledge, professional demeanor, a pleasure to speak with.

May 2022

•

Verified SHC Patient

he is one of best ever i have talked with

Jan 2022

•

Verified SHC Patient

Excellent explanation and friendly demeanor

Jan 2022

•

Verified SHC Patient

Great staff very helpful ðŸ˜Š

Jan 2022

•

Verified SHC Patient

I am very impressed with Dr.Diehn's quality of care and caring.

Sep 2021

•

Verified SHC Patient

Dr. Diehn saved my life few years back, you are not expecting me to say something that is not 100% good....right?. Just kidding, great doctor in a great facility.

Sep 2021

•

Verified SHC Patient

I am very pleased with both Dr. Dienh & Dr Ross. And I thank them for their time.

Jun 2021

•

Verified SHC Patient

Dr. Diehn was good at listening, answering questions, communicating medical information clearly and precisely. He was encouraging, assuring and we felt very supported.

May 2021

•

Verified SHC Patient

Good experience.

Sep 2019

•

Verified SHC Patient

My experience with radiation employees was always superb. Raymond, Annie & Karen in radiation.

Jul 2019

•

Verified SHC Patient

Very confident, clear explanations, courteous!

May 2019

•

Verified SHC Patient

Dr. Dienh provided one of the best experiences we had at Stanford. He and his team took time to explain all the details about the procedures.

Apr 2019

•

Verified SHC Patient

Good experience.

Mar 2019

•

Verified SHC Patient

Dr. Diehn is excellent doctor. He is world level. He is very positive. He warns me and encourage me to do everything better. Thanks.

Oct 2018

•

Verified SHC Patient

Dr. provided excellent explanation of my health care and upcoming treatments. I feel very confident in his care.

Oct 2018

•

Verified SHC Patient

Good experience.

Sep 2018

•

Verified SHC Patient

Excellent.

May 2018

•

Verified SHC Patient

Dr. Mancusa was one of the best of many exams I have had in prior visit with other NP's.

Mar 2018

•

Verified SHC Patient

Good experience.

Mar 2018

•

Verified SHC Patient

Good experience.

Oct 2017

•

Verified SHC Patient

Have referred a friend, he is also pleased with outcome & service.

Aug 2017

•

Verified SHC Patient

Good experience.

Jul 2017

•

Verified SHC Patient

Excellent!

Apr 2017

•

Verified SHC Patient

Excellent.

Mar 2017

•

Verified SHC Patient

Dr. Maximillian Diehn is phenomenal - I feel so blessed to be under his care.

Mar 2017

•

Verified SHC Patient

Good experience.

Dec 2016

•

Verified SHC Patient

Dr. Diehn & Gittrin are A++.

Oct 2016

•

Verified SHC Patient

"The best."

Aug 2016

•

Verified SHC Patient

He always takes time to answer questions - NEVER makes me feel stupid!

Jul 2016

•

Verified SHC Patient

Dr. Diehn always is the most friendly doctor I've had the privilege of talking with. I am very impressed with his expertise in his field and I am lucky to have him as my doctor.

Jun 2016

•

Verified SHC Patient

Good experience.

Apr 2016

•

Verified SHC Patient

The best.

Mar 2016

•

Verified SHC Patient

Dr. Diehn could share a foxhole with me anytime anywhere.

Feb 2016

•

Verified SHC Patient

I like Dr. Diehn very much.

Nov 2015

•

Verified SHC Patient

Everyone was great!

Sep 2015

•

Verified SHC Patient

A very good experience.

Jul 2014

•

Verified SHC Patient

Thorough and to the point. I ask for truth and was given it.

Dec 2013

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Maximilian Diehn, MD, PhD

Radiation oncologist

Get In Touch

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Radiation Oncology at Blake Wilbur Building Palo Alto, CA

Radiation Oncology at Blake Wilbur Building

CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur Palo Alto, CA

CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur

Thoracic Cancer Program in Palo Alto Palo Alto, CA

Thoracic Cancer Program in Palo Alto

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(46 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Maximilian Diehn, MD, PhD

Radiation oncologist

Get In Touch

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Radiation Oncology at Blake Wilbur Building Palo Alto, CA

Radiation Oncology at Blake Wilbur Building

CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur Palo Alto, CA

CyberKnife Stereotactic Radiosurgery Program at 875 Blake Wilbur

Thoracic Cancer Program in Palo Alto Palo Alto, CA

Thoracic Cancer Program in Palo Alto

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(46 reviews)

Referring Physicians

PHYSICIAN HELPLINE